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Chloride Intracellular Channels 1 and 4 function in distinct branches of the S1P 
signaling to regulate endothelial cell behavior and vascular development 
Irina Jilishitz 
Chloride intracellular channels (CLICs), 1 and 4 are expressed in endothelial 
cells where they promote cell proliferation, migration and vessel morphogenesis in vitro. 
Clic4-/- mice exhibit defects in retinal angiogenesis suggesting CLIC4 functions as an 
angiogenic regulator. S1P signaling, through S1P receptors S1P1 and S1P2, is essential 
for endothelial cell functions during vascular development. S1P treatment promotes 
CLIC4 localization to cell surface suggesting a link between CLICs and S1P pathways.  
Here we demonstrate that CLICs function in embryonic development, retinal 
angiogenesis and vascular permeability regulation. Clic1-/-;Clic4-/- embryos die in utero 
and exhibit severe growth restriction with vascular defects prior to death. Loss of Clic4 
in murine endothelium (Clic4ECKO) caused aberrant retinal angiogenesis characterized 
by reduced vascular outgrowth and increased vessel sprouting. Clic4ECKO mice exhibited 
increased vessel leakiness as assessed by a lung permeability assay.  
We establish that CLIC1 and CLIC4 function in distinct branches of the S1P 
pathway to promote angiogenesis. Knockdown of CLIC1 or CLIC4 in endothelial cells 
impeded S1P1-mediated induction of AKT and Rac1 and reduced endothelial cell 
migration and adherence junctions formation. CLIC1 knockdown alone inhibited RhoA 
activation and actin stress fibers downstream of S1P2. Using pharmacological 
perturbation of S1P signaling in Clic knockout mice we established that Clic4 is 
essential for S1P1-mediated regulation of retinal angiogenesis and vascular 
	  
	  	  
permeability. We conclude that CLIC1 and CLIC4 function as effectors in the S1P 
pathway, where they have overlapping functions in S1P1-PI3K signaling and CLIC1 
uniquely acts as an effector in S1P2-RhoA signaling cascade. Through these findings, 
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Angiogenesis in development and disease 
During embryogenesis, the circulatory system develops by two distinct processes 
titled vasculogenesis and angiogenesis. Vasculogenesis takes place first in the 
developing embryo where endothelial precursor cells merge together and differentiate to 
form a nascent vascular network of tubes. Vascularization of some organs, like the lung 
and pancreas depends entirely on vasculogenesis[1]. However, the majority of the 
circulatory system requires further angiogenic expansion and remodeling of the basic 
vascular plexus initially formed by vasculogenesis. Angiogenesis is the process through 
which new blood vessels are formed from pre-existing vasculature resulting in a stable 
hierarchal vascular network comprised of arteries, veins and intervening capillaries[2]. 
Angiogenesis is initiated when vascular endothelial growth factor A (VEGF-A) stimulates 
endothelial cells to degrade the local basement membrane surrounding an existing 
vessel[3]. VEGF-A stimulated endothelial cells being to proliferate, and migrate into the 
surrounding stroma forming nascent sprouts that proceed to form lumens in a process 
named tubulogenesis. After lumen formation, tubes branch and reconnect to form 
vascular networks. Mural cells such as pericytes and smooth muscle cells are recruited 
to stabilize the newly formed vessels and produce extracellular matrix components that 
reform the basement membrane[4]. The combination of these events establishes a 
mature vascular network capable of delivering nutrients and oxygen throughout the 
body of the organism. Normal progression of angiogenesis is essential for mammalian 
embryonic maturation, organ development, and tissue growth and repair. Deviations in 
angiogenic regulation lead to a variety of pathologies such as macular degeneration, 




critical for tumor growth, and metastasis[5]. Thus it is imperative to understand the 
molecular mechanisms and key regulators that drive the process of angiogenesis both 
in development and pathology.   
 
Chloride Intracellular Channels 
Chloride intracellular channel (CLIC) proteins are unique class of intracellular ion 
channels that were first identified as homologs of p64, a bona fide chloride ion channel 
functioning in kidneys[6]. CLICs are highly conserved among vertebrates and 
invertebrate and are widely expressed in multicellular organisms [7, 8]. In mammals, the 
CLIC protein family consists of six members, CLIC1-CLIC6[9-11]. CLICs have been 
shown to localize to different cellular compartments including plasma membrane[10], 
mitochondria[12], nucleus[10], Golgi[13] and endoplasmic reticulum[14, 15]. While 
CLICs have been implicated in diverse biological processes such as apoptosis[16], 
intracellular trafficking[17], cytoskeleton rearrangement[17, 18], phagosome 
acidification[19], cell differentiation[20, 21], and migration[22] in a variety of different cell 
types, their underlined mechanism of action is still poorly understood.  
 The prototypical CLIC protein structure is characterized by the presence of a 
conserved 240 amino acid module at the C-terminus whose structure belongs to the 
glutathione-S-transferase (GST) family[23]. Sequence analysis indicates that most CLIC 
family members possess a putative single pass trans membrane domain (TM) near the 
N- terminus[24] that allows the protein to insert itself into the membrane. CLIC family 
members are proposed to adopt two different protein conformation based on a single 




CLICs are reported to exist as either a soluble, cytoplasmic or an integral membrane 
protein, with the transition between these forms being regulated by either redox state[11, 
24-26] or pH[11, 27, 28]. In the case of CLIC1, the reduced form of the protein is 
predicted to function as a cytosolic monomer and exhibits a glutaredoxin-like 
glutathione-dependent enzymatic activity[29]. The crystal structure of the oxidized form 
of CLIC1 predicts that soluble CLIC monomers form non-covalent dimers that insert 
themselves into the lipid bilayer and oligomarize to from a putative chloride ion channel 
in transfected cells and in artificial lipid bilayers[24, 26, 30]. As there is no crystal 
structure for the integral membrane form of CLIC proteins nor is there evidence from 
single cell patch-clamp experiments supporting ion channel activity, the function of 
CLICs as bona fide chloride ion channels is still a matter of great debate.  
 
CLICs function in angiogenesis and vascular development 
CLIC proteins are regarded as novel regulators of angiogenesis. Originally, 
CLICs have been implicated as potential effectors in tubulogenesis, the process of 
lumen formation, which is an essential step in the angiogenic process. A study in C. 
elegans determined that Exc-4, a C-elegance homolog of CLIC4, is essential for the 
proper formation of intracellular tubes in the excretory canal of the worm[31], where 
Exc-4 mutants exhibited lumenal cysts and morphological defects at the surface of 
excretory canal[31]. A chimeric protein variant fusing human CLIC1 lacking the 
transmembrane domain to the putative transmembrane domain of Exc-4 rescued the 
cystic disruption phenotype in Exc-4 mutant [7], suggesting conservation of CLIC 




 Of the six known mammalian CLICs, only CLIC1 and CLIC4 are highly 
expressed in endothelial cells[32, 33]. Weak expression of CLIC5 was reported in 
placental[34] and glomerular[35] endothelial cells. Our laboratory has previously 
demonstrated that CLIC1 and CLIC4 promote endothelial growth and morphogenesis in 
vitro. Using assays with human umbilical vein endothelial cells (HUVEC), we have 
demonstrated that CLIC4 knockdown decreased cell proliferation, cell survival, capillary-
like sprouting, and lumen formation[32]. CLIC1 was shown to function in endothelial cell 
migration, proliferation, network branching and lumen formation[22].  
Genetic deletion of Clic1 (Clic1-/-) or Clic4 (Clic4-/-) in mice results in minimal 
phenotype in unstressed environments[33], however these mutant mice show various 
vascular defects[33],[36]. Mild platelet dysfunction and reduced clotting were observed 
in Clic1 knockout mice[36]. Clic4-/- knockout mice generated by our lab and others[33].  
demonstrated vascular defects in a matrigel plug angiogenesis assay, during retinal 
vascular development, and in adult mice challenged by an oxygen toxicity assay[33]. It 
was also noted that Clic4-/- mice had fewer collateral vessels in the brain and skeletal 
muscle, more readily leading to ischemia[37]. Clic4-/- mice were shown to have smaller 
kidneys with fewer glomeruli and less dense peritubular capillary networks[38]. 
Increased expression of CLIC proteins in tumors or their microenvironment has been 
associated with poor disease prognosis in multiple cancer type [39-41]. Taken together 
these results indicate that CLIC1 and CLIC4 function in endothelial cell angiogenesis, 
postnatal vascular development and are implicated in vascular pathogenesis.  
 




Sphingosine-1-phosphate (S1P) is an important mediator of various cellular 
functions in different cell types including those of the cardiovascular system, immune 
system, and the central nervous system all of which were previously reviewed[42].  S1P 
is a bioactive sphingolipid that is generated by the action of sphingosine kinase on 
sphingosine through the catabolism of ceramide[43]. S1P is enriched in blood in the 
submicromolar range, while its concentration in tissues is found to be much lower[44]. 
Platelets are reported to store abundant amounts of S1P and are considered be the 
major source of S1P in plasma[45]. The diverse biological functions of S1P are 
mediated by specific, high-affinity G-protein coupled receptors (GPCRs). Five receptors 
for S1P have been identified so far; S1P1-S1P5. In endothelium, S1P1, S1P2 and S1P3 
are the three major receptors expressed. S1P binding to its receptors activates their 
associated heterotrimeric G-protein and promotes downstream signal transduction 
through specific signaling branches.  
S1P1 exclusively binds to Gαi subunit of heterotrimeric G-protein, whereas 
S1P2 and S1P3 couple with Gαi, Gαq and Gα12/13[46]. Signaling through Gαi G-protein 
complex activates the Ras-ERK pathway to promote proliferation[47], the PI3K-AKT 
pathway to prevent apoptosis, and the PI3K-Rac1 pathway to promote cytoskeletal 
rearrangement, migration and assembly of VE-cadherin junctions[48] (Fig 1.1A). 
Activated Gαi also functions to inhibit adenylyl cyclase causing reduction in intracellular 
levels of cyclic adenosine monophosphate (cAMP)[49]. Activation of Gαq primarily 
induces the Phospholipase C (PLC) pathway, and signaling through Gα12/13 activates 
RhoA that inhibits Rac1 mediated migration and VE-cadherin junction formation[50] (Fig 




associated protein kinase (ROCK) leading to actin stress fiber formation, and 
endothelial cell contractility[50] (Fig 1.1A). The balance between signaling pathways 
downstream of each receptor subtype determines the divergent effects of S1P, 
depending on the expression pattern of S1P receptors in endothelial cells (Fig 1.1B).   
S1P and its receptors are critical regulators of vascular development. Both 
global and endothelial specific knockout of S1pr1 in mice results embryonic lethality 
between E12.5-E14.5 due to severe hemorrhage and cardiac edema[51]. In contrast, 
S1pr2 or S1pr3 global knockout mice are viable, fertile and do not exhibit apparent 
vascular defects[51]. After birth, S1pr1 signaling functions in postnatal retinal 
angiogenesis to promote vessel maturation and suppress extraneous sprout 
formation[52, 53].  
The balance between signaling downstream of S1P1 and S1P2 receptor tightly 
regulates vascular permeability induction. S1P1 promotes maintenance of the vascular 
barrier through Rac1-mediated assembly of VE-cadherin and ZO-1 junctions comprising 
the adherence and tight junctions in endothelial cells[48]. S1P2 signaling antagonizes 
S1P1 functions through RhoA-dependent inhibition of VE-cadherin junctions which leads 
to increased vascular permeability[54]. The S1P pathway has also been linked to tumor 
growth and metastasis. Elevated S1P levels are associated with increased tumor cell 
proliferation and invasion in multiple tumor types[55, 56] and blockade of S1P1 receptor 
inhibited tumor growth and metastasis[57]. Thus, S1P signaling regulates essential 
endothelial cell functions that are required for vascular growth in development and 
pathological conditions. 




and postnatal retinal angiogenesis and defines a molecular mechanism through which 
CLICs mediate their functions in endothelium. By analyzing mice with combined loss of 
Clic1 and Clic4 we determined that Clic1 and Clic4 are required for embryonic 
development and endothelial cell viability (Chapter 3). We found that postnatal 
endothelial-specific deletion of Clic4 results in abnormal retinal vessel development and 
increased lung vessel permeability (Chapter 4). We next sought to define a molecular 
mechanism through which CLICs mediate their functions in angiogenesis. A study by 
Ponsioen and colleagues linked CLICs to the S1P pathway by demonstrating that S1P 
treatment promotes CLIC4 translocation to the plasma membrane in tumor cells[58]. 
Accordingly, we hypothesized that CLICs function in S1P signaling to critically regulate 
angiogenesis. Analysis described in Chapters 5-7 establishes CLIC1 and CLIC4 as 
effectors in S1P signaling that function in distinct branches of S1P pathway to promote 
endothelial cell functions, G-protein mediated signal transduction, and S1P1-mediated 

























































Figure 1.1 S1P signal transduction pathway in endothelium  
A) S1P activates S1P receptors, S1P1–3, which transmit diverse intracellular signals depending 
their coupling with different heterotrimeric G-protein subtypes and the expression pattern of 
each receptor in endothelial cells. B) Balance between signals exerted through S1P1 and S1P2 
tightly regulates the process of angiogenesis. 
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Clic4fl/fl and Clic4-/- mice were constructed in our lab by Jennifer Tung, PhD. 
Clic1-/- mice were a gift from Dr. Samuel Briet[36] (University of New South Wales, 
Sydney, Australia) and genotyped used Clic1null primer set (Table 1). Cdh5-CreERT2 
transgenic mice were a gift from our collaborator Dr. Timothy Hla (Weil Cornell Medical 
Center). Cdh5-CreERT2 were crossed to Clic4fl/+, or Clic4fl/fl Clic4fl/fl;Clic1-/- mice. Cre 
gene presence was confirmed by PCR with Cre-Cdh5 primers (Table 1). 
Generation of Clic4fl/fl and Clic4-/- transgenic mice 
The pPNT1-5FEL3 targeting construct was given to Victor Lin at Columbia 
University Medical Center’s Comprehensive Cancer Transgenic Facility (New York, NY) 
for generation of chimeric mice. Briefly, the targeting construct was linearized using NotI 
and electroporated into CSL3 ES cells derived from 129S6/SvEvTac-Car3 mice. After 
negative selection against HSV-tk and neomycin (G418) selection, 192 ES cell clones 
were screened for homologous recombination using Southern blot analysis to confirm 
integration of the FNFL cassette. Correctly targeted ES cell clones were further 
screened for integration of the single loxP site by PCR using the LoxS primer set. From 
the eleven correctly targeted clones, two were chosen for microinjection into C56BL/6 
host blastocysts. Resultant chimeras were crossed with C57BL/6 mice and germline 
transmission was detected by agouti coat color. Germline transmission was confirmed 
by Southern blotting and PCR using LoxS primers. Chimeras were crossed with 
C57BL/6 mice to establish the Clic4fl mutation in a hybrid 129/B6 background. To 
generate Clic4-/- mice, female Clic4lf/fl mice were crossed with male EllaCre 




were then backcrossed with C57BL/6 mice for eight generations to produce Clic4 
heterozygotes in a pure B6 background. Clic4+/- mice were subsequently intercrossed 
to produce Clic4 global knockout mice in B6 background. Clic4-/- mice were genotyped 
by PCR using the forward primer from the FNFL primer set and the reverse primer from 
the LoxS primer set while Clic4flfl were genotyped using the two LoxS primers to confirm 
presence of LoxP sites (Table 1).  
Induction of endothelial Cre recombination 
Cdh5-CreERT2 animals were crossed to Clic4fl/+, or Clic4fl/fl Clic4fl/fl;Clic1-/- mice.  
Cre recombination was induced by oral gavage of mother with of 12.5µl/g of 20mg/ml 
Tamoxifen () dissolved in Corn oil (Sigma Aldrich). Gavage was performed at P1,P2 and 
P3 after birth. For retinal analysis, retinas were collected at P5 while lung EBD 
permeability assay was performed 4 weeks after birth and 3 weeks after tamoxifen 
induced Cre recombination. To confirm Cre recombination in retinal endothelium, Cdh5-
CreERT2 were crossed to mT/mG dual reporter mouse line which was a present from Dr. 
Peter Cannol (Columbia University medical center). Using Tamoxifen treatment schema 
above, Cre recombination was induced and retinas were analysed at P5.  
Whole mount immunohistochemistry 
Yolk sacs and extraembryonic membranes were removed from embryos during 
dissection, and embryos were fixed overnight at 4°C in 4% PFA. Embryos were then 
washed three times for 10 min each in PBS, once in 50% methanol (diluted in PBS) for 
10 min, and three times in 100% methanol for 5 min each. Dehydrated embryos were 
then bleached for 5 hr in methanol:DMSO:H2O2 (4:1:1) at room temperature for 5 hr. 




PBT (0.2% BSA, 0.5% Triton X-100 in PBS), two 5-min washes in PBSMT (2% milk, 0.5% 
Triton X-100 in PBS), three 15-min washes in PBSMT, and one 1-hr wash in PBSMT, 
embryos were incubated with rat anti-mouse endomucin (1:200, Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) in PBSMT overnight at 4°C with rocking. Embryos 
were then washed in 4°C PBSMT twice for 5 min, thrice for 15 min, and then seven 
times for 1 hr before incubation with HRP-conjugated goat anti-rat secondary antibody 
(1:2000, Sigma-Aldrich, St. Louis, MO) at 4°C overnight with rocking. To visualize 
staining, embryos were first washed with PBSMT at 4°C twice for 5 min, thrice for 15 
min, and five times for 1 hr before two 5 min and three 15min washes with PBT at room 
temperature. Embryos were then incubated for 15 min in DAB solution (250 µg/mL DAB, 
0.08% NiCl2 in PBT) before the addition of H2O2 at 1:1000. All embryos within a 
matched set were allowed to incubate in the H2O2 solution for the same amount of time, 
and the color reaction was stopped by rinsing embryos twice in PBT. After postfixing 
overnight at 4°C in 4%PFA, embryos were washed three times with PBT and 
cryopreserved with 80% glycerol in a series (10 min room temperature wash with 25% 
glycerol, 10 min in 50% glycerol, and 10 min in 80% glycerol), embryos were analyzed 
using NIS-Elements software on a Nikon SMZ1000 (Nikon, Inc., Melville, NY). Each 
experiment was repeated with littermate controls at least 5 times.  
Retina whole mount analysis 
Following sacrifice, eyes were enucleated and fixed in 4% PFA for 2 hours at 
4°C. Retinas were then dissected out and incubated in 0.5% Triton-X-100, 1% BSA, 
overnight at 4°C. Following washes in PBLEC (1% Triton-X-100, 1mM MgCl2, 1mM 




containing biotinylated Isolectin-B4 (VectorLabs, 1:50) .On the following day, retinas 
were washed 3 times with PBLEC for 30 minutes each wash, and then 3 times with 
PBLEC diluted by half with 1XPBS (PB/2) for 30 minutes each wash. Retinas were 
incubated with Alexa Fluor conjugated secondary antibodies (Invitrogen) diluted at 
1:500 in PB/2 overnight at 4°C or for 2 hours at room temperature while shaking. 
Retinas were then washed 4 times for 15 minutes each wash in PBLEC diluted by 1⁄4 
with 1xPBS (PB/4) followed by a single 10-minute wash with 1XPBS. To ensure 
longevity of staining retinas were post-fixed with 4% PFA for 15 minutes at room 
temperature. Retinas were then washed several times with 1XPBS prior to mounting on 
slides with mounting media containing 90% glycerol in 0.1M Tris pH 8 and 1 µg/ml of 
Hoechst nuclear stain (Sigma). Following that, retinas were flat-mounted with 
VectaShield mounting medium (Vector Labs, Burlingame, CA), and visualized using 
ACT-1 software on a Nikon ECLIPSE E800 microscope (Nikon, Inc., Melville, NY). 
ImageJ was used for all quantifications. For retinal vessel density quantification, 10X 
images were taken of each leaflet of each retina. The vascular area was outlined and 
then the percent coverage of Isolectin-B4 staining of total vascularized area was 
obtained by thresholding the image. For vessel outgrowth, 4X images were taken of 
each retina and vessel length was measured from optic nerve to beginning of vascular 
front in micrometers. For branch point and tip cell number, 20X images were taken, 10 
images per retina and tip cells and branch points were counted.  
Quantification of retinal density, outgrowth, branch points and tip cells 
ImageJ was used for all quantification. For retinal vessel density quantification, 




and then the percent coverage of Isolectin-B4 staining of total vascularized area was 
obtained by thresholding the image. Vessel outgrowth was quantified by measuring the 
distance from the optic nerve to the edge of the vascular front for each leaflet. No 
significant difference in body weight was observed between genotypes (data not 
shown). Branch point and tip cells were counted using 20X images, 8 images per retina.  
Cells and culture 
HUVEC were isolated from human umbilical veins as previously described [186] 
and cultured on dishes coated with type I rat tail collagen (VWR, West Chester, PA) in 
EGM-2 BulletKit medium (Lonza, Basel, Switzerland). Detroit 551 fibroblasts and 293T 
fibroblasts were purchased from ATCC (Manassas, VA) and cultured in Eagle’s 
Minimum Essential Medium (EMEM) (ATCC, Manassas, VA) and Iscove’s Modified 
Dulbecco’s Medium (Invitrogen, Carlsbad, CA), respectively. Both media were 
supplemented with 10% FBS (Invitrogen, Carlsbad, CA), and 0.01% Pen-Strep 
(Invitrogen, Carlsbad, CA). Unless otherwise noted, cells were cultured under standard 
conditions in a humidified incubator at 37°C, 5% CO2. 
Gene silencing and overexpression 
Human CLIC4 shRNA-containing constructs were purchased from Sigma– 
Aldrich (St. Louis, MO) and screened for significant Clic4 knockdown in HUVEC by 
immunoblotting as described below. Oligonucleotides were provided in lentiviral vector 
pLKO.1-puro, which carries puromycin resistance allowing for selection of shRNA- 
expressing cells. Two shRNA were selected with the target sequences of 5′- 
GCATATAGTGATGTAGCCAAA-3′ and 5′-GCCGTAATGTTGAACAGAATT-3′ denoted 




expressing a scrambled shRNA insert that does not target any known genes, served as 
a control. A human Clic1 shRNA-containing construct in lentiviral vector pLKO.1-puro 
(Sigma-Aldrich, St. Louis, MO) was used to provide Clic1 knockdown in HUVEC, which 
was confirmed by immunoblotting. The Clic1-targetting shRNA possessed the target 
sequence of 5'-CCTGTTGCCAAAGTTACACAT-3'. Again, lentiviral vector pLKO.1-puro 
expressing scrambled shRNA was used as the control (Sigma-Aldrich, St, Louis, MO).  
Full-length human CLIC4 cDNA was prepared by RT-PCR using mRNA from HMVEC 
(human dermal microvascular endothelial cells) with the following primers: 5′-
ATGGATCCGCCACCATGGCGTTGTCGATGCCGCTGAATG-3′ forward and 5′- 
ATGTCGACTTACTTGGTGAGTCTTTTGG-3′ reverse. The sequence of the cloned 
CLIC4 was determined and found to be identical with that of human CLIC4 (AF097330) 
except for a G to A nucleotide change in position 291, which did not affect the coding 
sequence. The full-length CLIC4 cDNA was cloned into lentiviral pCCL.pkg.wpre 
(referred to as pCCL-CLIC4) and screened for significant Clic4 overexpression by 
immunoblotting.  
Lentivirus-mediated stable expression of shRNA and full-length constructs in 
HUVEC 
For lentiviral gene transfer, the lentiviral vector pLKO.1 was used for shRNA 
knockdown lines while pCCL was used for the overexpressing HUVEC line. About 2.5 × 
106 293T packaging cells were seeded and transfected with 3 µg pVSVG, 5 µg 
pMDLg/pRRE, 2.5 µg pRSV-Rev, and either 10 µg pLKO.1-Clic4 shRNA (CLIC4 
knockdown), pLKO.1-Clic1 shRNA (CLIC1 knockdown), pLKO.1-scrambled shRNA 
(knockdown control), pCCL-CLIC4 (CLIC4 overexpression), or pCCL-GFP 




after transfection, passed through a 0.45 µm filter, and added to 1 × 106 low-passage 
HUVECs. About 48 h after infection, pLKO.1-expressing HUVECs were selected with 
puromycin (3 µg/ml) for 72 h and maintained with puromycin at 1.5 µg/ml. 
Immunoblotting 
HUVEC protein lysates were prepared in TENT lysis buffer (50 mM Tris pH 8.0, 
2 mM EDTA, 150 mM NaCl, and 1% Triton X-100) containing Protease Inhibitor Cocktail 
Set IV (EMD Chemicals, Inc., Gibbstown, NJ) prepared according to the manufacturer's 
protocol. Lysates were boiled for 5 min after addition of SDS and β-mercaptoethanol- 
containing sample buffer. Protein concentrations were determined using the Bradford 
protein assay (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer's 
protocol, and sample volumes were adjuste).d to equivalent concentrations for equal 
protein loading into SDS-PAGE. Protein was then electroblotted onto nitrocellulose 
membrane and blocking occurred in 5% milk dissolved in PBST (1× PBS with 0.2× 
Tween20). Incubation of primary antibody was done in 2.5% milk dissolved in PBST, 
and incubation of secondary antibody (1:5000 for both HRP-conjugated goat anti-rabbit 
and goat anti-mouse) occurred in 2.5% milk in PBST. Protein bands were visualized 
using Enhanced Chemiluminescence (GE Healthcare Bio-Sciences Corp., Piscataway, 
NJ) according to the manufacturer's protocol. Secondary goat anti-rabbit and goat anti-
mouse horseradish peroxidase (HRP)-conjugated antibodies were purchased from 
Sigma- Aldrich (St. Louis, MO) 
Apoptosis assessment by FACS 
Annexin V staining was performed using apoptosis assessment kit from 




collected for each cell line and resuspended in 1X binding buffer. Cells suspensions 
were incubated with 1:100 annexin V-FITC conjugated antibody (Biovision) and placed 
on ice for FACS analysis. The BD FACSCalibur was used to perform flow cytometry 
according to the manufacturer's protocol and data analysis was performed using CD 
CellQuest Pro software (San Jose, CA).  
EBD lung permeability assay  
Pulmonary vascular leakage was measured by Evan blue dye (EBD) 
accumulation assay reported previously[59]. EBD (1% in saline) was injected 
intraperitoneally 3 hours before tissue harvest. Lungs and livers were removed, 
photographed, weighed, and freeze-dried at 56°C overnight. To quantify EBD 
accumulation in lungs, dry lung weight was measured again, and lungs tissue with EBD 
was dissolved in formamide (Sigma-Aldrich) at 37°C for 24 hours. EBD extravasation 
was quantified spectro- photometrically using 96 well plate reader at 620 and 740 nm. 
EBD extravasation was adjusted per weight of tissue. 
Immunofluorescence  
Cells were plated on poly-l-lysine coated cover slips in 24 well dishes and 
allowed to settle for 24 hours. Cell were then washed 3 times with cold PBS and 
permiabalized with 0.1% TritonX/PBS for 10 min. Cells were washed once with 1X PBS 
and blocked with 5% donkey serum in PBS with 10% BSA for 30 min. following blocking 
cells were incubated with primary antibody (see Table 2) diluted in blocking solution 
over night at 4 °C. Following day cells were washed X3 with PBS, 5 min each, 
incubated secondary antibodies like Alexa Fluor 594 and Alexa Fluor 488 ( both at 




Cells were then washed with 1X PBS, 3 times, 5 min each and mounted on slides 
VectaShield with DAPI (Vector Labs, Burlingame, CA). Slides were imaged using CT-1 
software on a Nikon ECLIPSE E800 microscope (Nikon, Inc., Melville, NY). 
Quantification was done using Image J software (NIH, Bethesda, MD). 
S1P Boyden chamber migration assay 
Chemotaxis towards S1P was assessed in modified Boyden chamber assay[60].  
HUVEC cells were starved for 3 hours in serum free EBM2 culture media (Lonza) 
containing 0.1% fatty acid free BSA. Starved cells were seeded at identical 
concentrations in triplicate in the top part of a 96 well boyden chamber. Different 
concentrations of S1P ranging from 10 nm to 1µM in SFM were placed in the bottom 96 
well chamber. In the middle, a polycarbonate 8µm pore filter was placed. Cells were 
allowed to migrate towards S1P for 4 hours in tissue culture incubate set at 37°C and 
5% CO2. After 4 hours, filter was removed, stained with Crystal violet dye to visualize 
cells and imaged. Cell migration was quantified using a 96 well plate reader at 595nm 
absorption wavelength. When using with VPC44116 (Table3), HUVEC were first 
incubated with 1µM vpc44116 diluted in SFM for 1 hour prior seeding in boydem 
chamber. S1P and VPC44116 were mixed together to allow cells to migrate in constant 
presence of the inhibitor.  
3D Collagen invasion assay 
3D collagen invasion assay mediated by S1P was performed in the laboratory of 
Dr. Kayla Bayless (Texas A&M) as previously described[61]. HUVEC cells with control 




matrices. Collagen gels (80 ll) were prepared at a final concentration of 2.5 mg/ml[62]. 
Using a Transwell system (Corning-Costar), gels were placed into 6 mm culture inserts, 
allowed to polymerize, and equilibrated at 37 C and 5% CO2. Control, CLIC1-KD or 
CLIC4-kd HUVECs  (50,000/well) were added to the upper chamber in 100 ll M199 
containing reduced-serum II supplement (Transferrin, BSA, oleic acid, and insulin), 40 
ng/ml bFGF and VEGF (Upstate Biotechnology), 50 lg/ml ascorbic acid, and 50 ng/ml 
phorbol ester. The lower chamber received 1 ml of identical media and varying doses of 
S1P. Cultures were allowed to develop for 24h at which time the media in the upper well 
were changed. Experiments continued for 48h before being fixed in 3% glutaraldehyde 
in PBS stained with 0.1% toluidine blue in 30% methanol and destained. Intact cultures 
were photographed using an upright Nikon microscope and Olympus camera and 
Kodachrome 64T color slide film. Intact cultures were quantitated using an eyepiece 
equipped with an ocular grid. Three random fields at 10X magnification were selected 
and the number of invading cells per high power field (HPF) was counted manually.  
VE-cadherin junction formation 
VE-cadherin junction formation was assessed as described previously[63]. 
HUVEC cells were seeded at 80% confluency on poly-lysine coated cover slips in 24 
well dishes 24 hours prior to experiment and cultured in EBM2 reduced serum media 
containing 2% FBS. Next day, cells were washed once with cold PBS and 3 times with 
starvation media containing serum free EBM2 and 0.1% fatty free BSA. Following 
starvation HUVECs were stimulated with 100nm S1P for 1 hour. After stimulation cells 
were fixed with 4% PFA/PBS and washed with PBS 3 times, 1 ml/well. Imunnoflourence 




(Table 2).  Quantification of VE-cadherin positive signal was performed by imageJ 
analysis using skeletonized images of cells and quantifying positive signal on cell 
perimeter. When VPC44116(Table3) was added in rescue experiments, 1µM 
VPC44116 in starvation media was added 1 hour prior to S1P stimulation. In inhibitor 
group, VPC44116 and S1P were added together to maintain constant inhibition.  
Actin stress fiber formation assay 
Actin stress fibers in HUVECs with control or CLIC knockdown were assessed 
by co-immunoflouresence analysis with Actin Phalloidin and Dapi to visualize cell nuclei 
(Table 2). Briefly, HUVEC cells were seeded at 80% confluency 24 hours prior to 
experiment in 12 well collagen coated dishes. Prior to S1P stimulation, cells were 
starved for 3 hours in EBM2 serum free media containing 0.1% fatty acid free BSA/PBS. 
Cells were then stimulated with 100 nm S1P for 1 hour and fixed with 4% PFA/PBS for 
15 min, RT. Immunoflouresnce was performed as described above using actin 
phalloidin fluorescently conjugated antibody(Table 2).  
G-lisa Rac1, RhoA or Ras activation assay 
Assays were performed using Rac1(BK126), RhoA (BK124) or Ras(BK131) 
activation kits purchased from Cytoskeleton. Briefly, HUVECs with CLIC knockdown or 
overexpression were cultured and on 6 well plates for 72 hours at 60% confluency prior 
start of the experiments. Cells were starved in EBM2 serum free media with 0.1% fatty 
acid free BSA for 3 hours. Then stimulated with 1µm S1P for 1-30 min. After 
stimulations cells were harvested and lysed based on protocol provided from 
Cytoskeleton. Lysates were immobilized on GTP-bound capture plate and G-lisa was 




FTY720 and SEW2871 administration  
To examine retinal vessel development at P5 we injected intraperitoneally pups 
at P1,P2 and P3 with SEW2871 in 10% ethanol/PBS or vehicle control (10% 
ethanol/PBS) Retinas were harvested at P5 for analysis as described above. 
To examine lung vessel permeability, 24 hour prior to EBD administration animals 
injected intraperitoneally with 0.5mg/kg or 2mg/kg of FTY720 diluted in 1%Ethanol/PBS 
or vehicle (1% Ethanol/PBS). EBD permeability assay was performed 24 hours after 
that as described above.   
S1P1 internalization assays 
HUVEC cells were lentivirally infected with S1P1:GFP fusion construct together 
with shRNA targeting either CLIC1 or CLIC4. HUVEC cells were starved for 6 hours in 
serum free EBM2 supplemented with fatty acid free BSA. After starvation, cells were 
treated with 1µM S1P for 1 hour. Cells were fixed with 4% PFA, washed with PBS and 
mounted on slide with vectorshield DAPI. Images were visualized with ACT-1 software. 
Statistics 
Unless otherwise noted, independent two-tailed Student’s t-tests were 
performed on all quantified data to determine significant differences between two means. 
Pearson’s χ2 testing was used to determine goodness of fit between observed genotype 
distributions and theoretical Mendelian distributions during in vivo analyses. P values 
less than 0.05 were considered statistically significant, and equal variances were 
assumed. Unless otherwise noted, experiments were repeated at least three times. 
 

























Primer Sequence (5’-3’) 
Clic4 mutant Forward  ACCATGACCACGGCAACTCCTA 
Clic4 mutant Reverse  TGCAATTGGACCCCATGTGTGTGTG 
Clic1 mutant Forward GGAAGCCGTGTTGGAGCGAACTAA 
Clic1 mutant Reverse GAACAGTCAGTGCTCTTAACTGCT 
Clic4 conditional (fl) Forward TGCAATTGGACCCCATGTGTGTGTG 
Clic4 conditional (fl) Reverse  GGAGCCCTGAAGGCCAAGGTTT 
Cre Forward GATATCTCACGTACTGACGG 





























VE-cadherin Rabbit Abcam Ab33168  IF 1:250 
GFP Rabbit Thermo Fisher A6455 
 
IF 1:500 
AKT Rabbit Cell Signaling 9272S 
 
Western blot 1:1000 
Phospho-AKT Rabbit Cell Signaling 9271S 
 
Western blot 1:1000 
ERK Mouse Cell Signaling 4695 
 
Western blot 1:1000 
Phospho-ERK Rabbit Cell Signaling 4370 
 
Western blot 1:1000 
Phalloidin-Actin 
546 Mouse Thermo Fisher A22283 
 
IF 1:500 
CLIC4 Rabbit Abcam Ab76593  Western blot 1:250 
CLIC1 Rabbit Abcam Ab77214 
 
Western blot 1:150 
Tubulin Mouse Sigma Aldrich 32-3600 
 






























Compound Function Company Concentration 















Antagonist Sigma Aldrich 0.5 mg/ml 
Pertussis 
Toxin Gαi Inhibitor Sigma Aldrich 1 mg/ml 
Gallein Gβγ Inhibitor Tocris 10 mg/ml 













Clic1 and Clic4 are required for embryonic development and 





This chapter contains excerpts from a paper I have co authored that is currently in 
review in Journal of Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) titled: 
Clic1 and Clic4 function in murine embryonic and retinal angiogenesis 





The process of angiogenesis through which new capillaries are formed from pre-
existing vessels requires numerous cellular processes including endothelial cell 
proliferation, migration and network formation[3]. Members of the CLIC family have 
been identified as novel regulators that promote angiogenic functions in endothelial cells. 
CLICs are highly conserved among both vertebrates and invertebrate[7, 8] and, in 
mammals consist of 6 CLIC family members CLIC1-CLIC6[9-11]. Mammalian CLICs are 
ubiquitously expressed and are shown to localize to different cell compartments 
including plasma membrane[10], mitochondria[12], Golgi[13] endoplasmic reticulum[14, 
15], and nucleus[10] based on studies in various cell types. CLIC proteins have also 
been implicated in diverse biological processes such as membrane remodelling[17], 
apoptosis[16], intracellular trafficking[17], cytoskeleton reorganization [17, 18], vacuole 
acidification[19], cell differentiation[20, 21], and migration[22]. 
CLICs are considered to function as putative intracellular ion channel proteins, 
consisting of a soluble, cytoplasmic or an integral membrane protein forms, where the 
transition between these two forms being regulated by either redox state[11, 24-26] or 
pH[11, 27, 28]. CLIC ion channel activity is predicted based upon the ability of several 




26, 30]. Whilst there are no concrete evidence that CLICs form selective integral 
membrane proteins in single cells nor is there structure for the integral ion channel 
membrane form, the glutaredoxin-like structure of the soluble CLIC protein has lead 
many to question whether it is an ion channel protein; see review[11]. 
In C. elegans, CLIC4 homolog Exc4 is essential for the proper assembly of 
intracellular tubes that comprise the gut of the worm and for maintenance of this tubular 
structure[31]. A chimeric protein fusing human CLIC1 lacking the transmembrane 
domain to the putative transmembrane domain of Exc-4 rescued the cystic disruption 
phenotype in Exc-4 mutant excretory canal[7], suggesting conservation of function 
across species and functional overlap between CLIC1 and CLIC4. 
Out of 6 mammalian CLICs, CLIC1 and CLIC4 are the only ones highly 
expressed in cultured endothelial cells[32, 33] and are thought to function critically in 
mammalian vascular development. Our lab has previously demonstrated that either 
CLIC1 or CLIC4 are essential for endothelial cell growth and morphogenesis[22, 32]. 
Mice with global loss of Clic1 (Clic1-/-) or Clic4 (Clic4-/-) show various vascular 
defects[33],[36]. Clic1 knockout mice did not appear to develop vascular disparities but 
exhibited a mild platelet dysfunction and reduced clotting phenotypes[36]. Clic4-/- 
knockout mice demonstrated vascular defects in a matrigel plug angiogenesis assay, 
aberrant development of the retinal vasculature and improper vascular regeneration in 
adult mice challenged by an oxygen toxicity assay[33]. Taken all together these data 
indicate that CLIC1 and CLIC4 are important regulators of postnatal vascular 




As both CLIC1 and CLIC4 regulate key angiogenic processes in endothelial cells, 
we sought to determine whether Clic1 and Clic4 function during embryonic development 
by generating mice with combined loss of Clic1 and Clic4. We found that loss of both 
these CLIC proteins leads to embryonic lethality with embryos exhibiting reduced 
vascular development followed by embryonic growth restriction. We also determined 
that combined loss of both CLIC1 and CLIC4 in endothelial cells results in robust 
induction of apoptotic cell death. We conclude that CLIC1 and CLIC4 are essential for 





Clic4 loss results in reduced embryonic viability and defects in postnatal retinal 
angiogenesis 
To examine the roles of CLICs in vascular development we defined the 
phenotypes of Clic1 or Clic4 global knockout mice. Specifically, we used Clic1-/- mice[36] 
and engineered a mouse line with a floxed conditional allele of Clic4 (Clic4fl/fl) [Jennie 
Tung Thesis] that when recombines with cre-recombinase deletes the sequence 
encoding the putative pore-lining α-helix and second β-sheet of the transmembrane 
domain (PTM), suggested to be responsible for the proper localization and function of 
CLIC4 [24, 25]. Clic4fl/fl mice were crossed with mice harbouring Rosa-cre[64], which 
drives cre-recombinase ubiquitously in the mouse, to generate Clic4 null mice [Jennie 
Tung thesis].   
We sought to determine if global loss of Clic4 affects murine embryonic 




E9.5 but were underrepresented at P21 (Table 1). To evaluate embryonic phenotypes 
of Clic1-/- or Clic4-/- mutant embryos, we focused on vascular assessment of E9.5 
embryos, a period of development with active angiogenesis, using the endothelial 
marker endomucin. We found Clic1-/- and Clic4-/- embryos to be phenotypically 
indistinguishable from wild type littermates and did not display overt vascular 
phenotypes at E9.5 (Fig 3.1A). Isolectin B4 (IB4) staining of neonatal retinas from Clic1-
/- showed normal vascular formation (Fig 3.1B). Thus, we determined that CLIC1 is not 
required for vasculogenesis or angiogenesis in the neonatal mouse. Retinas from Clic4-
/- mice showed an angiogenic defect in the deeper vascular plexus of the retina at 
postnatal day 9 (P9). Relative to wild type and Clic4+/- mouse retinas, Clic4-/- mutant 
retinas exhibited thinner calibre vessels (Fig 3.1C), and reduced number of branch 
points (Fig 3.1D); both phenotypes that had been previously reported [33].  
 
Loss of Clic1 and Clic4 leads to cardiac edema and embryonic death at E10.5  
Of the 6 known CLIC family members, cultured endothelial cells primarily express 
CLIC1 and CLIC4 both of which promote endothelial cell viability and growth [22, 32]. 
Thus, we hypothesized that the two endothelial CLICs may functionally overlap during 
murine vascular development. We intercrossed Clic1-/-;Clic4+/- mice to obtain Clic1-/-
;Clic4-/- embryos for comparison with control Clic1-/-;Clic4+/+ littermates. Clic1-/-;Clic4-/- 
mice were absent at birth (Table 2). At E10.5, double null embryos were not viable and 
displayed growth retardation, enlarged hearts, cardiac edema, and vessel hemorrhaging 





Clic1 and Clic4 double null embryos are embryonic lethal and display growth 
restriction with vascular defects   
At E9.5, Clic1-/-;Clic4-/- embryos were viable and upon dissection were present at 
the expected frequency (Table 2). However, E9.5 Clic1-/-;Clic4-/- embryos were 
significantly growth retarded compared to littermate controls (Fig 3.3A), with an average 
of 23 somites as compared to control litter mates with 27 somites (Fig 3.3A). Endomucin 
whole mount analysis revealed reduced vascular density and aberrant vascular 
architecture, suggesting overlapping roles for CLIC1 and CLIC4 in embryonic vascular 
development (Fig 3.3 B,C).  
 
E9.25 Clic1-/-;Clic4-/- embryos display reduced density of intersomitic  vessels and 
brain capillary plexus prior to growth restriction 
At E8.5 and E9.0, embryonic vasculature in Clic1-/-;Clic4-/- embryos appeared 
similar to control littermates (data not shown), indicating that vasculogenesis occurred 
normally. To determine if the vascular defects in Clic1-/-;Clic4-/- double mutant embryos 
occur prior to the embryonic growth restriction, we examined vascular development at 
the 23 somite stage (E9.25). E9.25 Clic1-/-;Clic4-/- embryos were at a similar 
developmental somite stage and the aorta and cardinal vein appeared unaffected as 
compared to control littermates (Fig 3.4A). However, Clic1-/-;Clic4-/- embryos displayed 
reduced endothelial content in the intersomitic vessels with the most affected region 
from the otic vesicle to below the developing heart (Fig 3.4A,B) and reduced capillary 
network branching in the head (Fig 3.4A,C). Taken together we found that the vascular 
defects in double mutant embryos occurred prior to the growth restriction. Thus 




angiogenesis, and these vascular defects likely contribute to the observed embryonic 
lethality.  
 
Combined CLIC1 and CLIC4 knockdown in endothelial cells results in reduced 
viability and induction of apoptosis 
As Clic1-/-;Clic4-/- embryos exhibited embryonic vascular growth defects and we 
have previously demonstrated that knockdown of either CLIC1 or CLIC4 in HUVEC 
decreased cell viability [22, 32], we hypothesized that both CLIC1 and CLIC4 are 
required to promote endothelial cell growth. We thus determined the effect of combined 
loss of these CLIC proteins in HUVEC growth and viability. HUVEC were co-infected 
with lentiviruses encoding CLIC1 and CLIC4 specific shRNAs and reduced protein 
levels were validated by immunoblotting (Fig 3.5A). Combined knockdown of CLIC1 and 
CLIC4 resulted in more rounded up cells (Fig 3.5B) and increase in number of floating 
cells. Quantification of the number of trypan blue negative cells by cell counting 
revealed reduced cell viability 24 hours after infection (Fig 3.6A). At 24 and 36 hours 
post infection, the apoptotic marker annexin V was significantly increased in double 
knockdown HUVECs, as compared to single CLIC1 or CLIC4 knockdown cells (Fig 
3.6B). By 48 hours post infection, annexin V levels were induced in more than 60% of 
double knockdown HUVECs, while only 20% of cells with single CLIC1 or CLIC4 
expressed annexin V (Fig 3.6B). These results indicate that both CLIC1 and CLIC4 are 







We previously established that individually, CLIC1 and CLIC4 promote 
endothelial cell survival and morphogenesis in vitro[22, 32]. Here, we report that 
combined loss of CLIC1 and CLIC4 in cultured endothelial cells caused apoptotic cell 
death, demonstrating that these CLIC proteins are essential to maintain endothelial cell 
viability. We, and others, have demonstrated Clic1 knockout animals are viable and 
fertile with no apparent vascular abnormalities. In contrast, we found that some Clic4 
nulls die during embryogenesis or soon after birth. Double Clic1 and Clic4 global 
knockout mice died between E9.5 and E10 and exhibited reduced vascular density and 
severe growth restriction. Just prior to the observed growth restriction, at E9.25, Clic1-/-
;Clic4-/- embryos had reduced vascular density and aberrant vascular architecture in 
both intersomitic and brain capillary networks. Taken together, these data demonstrate 
that CLIC1 and CLIC4 functionally overlap to promote endothelial cell viability in vitro, 
and murine embryonic development.   
Double null embryos for Clic1 and Clic4 are embryonic lethal and exhibit growth 
retardation, cardiac edema and vascular abnormalities prior to death. As the combined 
loss of Clic1 and Clic4 occurs globally, affecting all cell types, it is possible that the 
observed growth restriction arises from multiple cell deficiencies. We thus identified 
vascular defects at a stage of development (23 somites) when no growth restriction was 
apparent in double mutants. E9.25 Clic1-/- ;Clic4-/- embryos developed to the 23 somite 
stage, similar to control littermates, but had reduced vascular density in brain capillary 
plexus and abnormal vessel patterning of the intersomitic vessels. Although it is unclear 




to the observed embryonic death. Both the dorsal aorta and the cardinal vein are 
discernible in double Clic1-/-;Clic4-/- mutants, therefore it is unlikely that embryonic death 
occurred due to defects in vasculogenesis. This does not preclude the possibility that an 
additional member of the Clic gene family is expressed in the vasculogenic endothelium 
that was able to functionally compensate for the combined loss of Clic1 and Clic4. As  
We found that loss of CLIC1 and CLIC4 leads to reduced endothelial cell 
viability in cultured cells suggesting that the vascular defects in the Clic1-/-;Clic4-/- 
embryos may arise due to increased endothelial cell apoptosis during embryonic 
angiogenesis. Loss of cell viability in double null embryo vessels could result in vessel 
occlusion or retraction leading to reduced endothelial content and abnormal vessel 
patterning observed in Clic1-/-;Clic4-/- embryos at E9.25 and E9.5.  Alternatively, as 
knockdown of CLIC1 or CLIC4 results in defects in HUVEC network formation[22, 32], it 
is possible that combined loss of Clic1 and Clic4 in vessels leads to improper sprouting 
in the intersomitic vessel region and brain capillary plexus.  
Of the six mammalian CLICs, CLIC1 and CLIC4 are the two main CLICs 
reported to be expressed in endothelial cells[21, 22, 32, 33]. These two CLIC family 
members share 67% sequence identity with high degree of structural homology[26], 
consistent with their observed overlapping functions in embryogenesis and the 
endothelium. Notably, both CLIC1 and CLIC4 can localize in the cell to either the 
plasma membrane[18, 26] or the cytoplasm[24]. Localization of both CLIC1 and CLIC4 
are regulated by F-actin when reconstituted in planar lipid bilayers[65], suggesting 
overlapping roles in cytoskeletal reorganization. These CLICs are implicated in cell 




CLIC1 localization was reported to the apical domain in several columnar epithelia 
associated with apical membrane recycling[66]. Little is known as to the precise role of 
CLICs in trafficking but observations point to similar functions in endothelium. Both 
CLIC1 and CLIC4 have overlapping functions in regulating proliferation, tube formation 
and capillary-like network development in endothelial cells[22, 32]. These similarities in 
their protein structure, cell expression patterns, and overlapping functions in 
endothelium suggest that CLIC1 and CLIC4 compensate for each other during critical 
processes required for endothelial cell functions and vessel development.  
We demonstrated that CLIC1 and CLIC4 cooperate in endothelial cells to 
promote cell viability and prevent induction of apoptosis. While single knockdown of 
CLIC1 or CLIC4 markedly reduces cell proliferation and modestly affected viability, 
double knockdown of both CLIC1 and CLIC4 caused a rapid induction of apoptosis; 
apoptosis was detected with in 24hrs hours of knockdown, and more than half of the 
cells were undergoing apoptosis by 48 hours. Cooperation between Clic1 and Clic4 has 
been implicated in collateral vessel development. Clic4-/- mutant animals exhibited a 
defect in collateral vessel formation, leading to ischemia, and CLIC1 is significantly up-
regulated in these mutants suggesting compensation[37]. The phenotype we observed 
in Clic1-/-;Clic4-/- embryos indicates that CLIC1 and CLIC4 cooperate during embryonic 





















 Figure 3.1 Embryonic vascular development is unimpaired in Clic1-/- and Clic4-/- embryos, 
though Clic4-/- mice display reduced deeper plexus vascular density in the retina 
A) Whole mount endomucin staining of E9.5 Clic1-/-, Clic4-/- and wild-type embryos to visualize 
the vasculature. B) Whole mount staining with isolectin of Clic1-/-, Clic4-/- and wild-type P5 
retinas. artery (A), vein (V) C) Whole mount isolectin staining of P9 deep vascular plexus in 
Clic4-/- and wild-type retinas. White arrows indicate truncated vascular sprouts and abnormal 
vascular structures. D) Quantitation of branch points in the deep plexus of Clic4-/- and wild-type 
P9 retinas. **p<0.005. Scale bars; 200µm (A-B), 100µm (C) 	    
Clic1-/- Clic4-/- A wild type 
Clic1-/- Clic4-/- B 



























Figure 3.2 Loss of Clic1 and Clic4 causes embryonic lethality and cardiac edema at E10.5 
E10.5 Clic1-/-;Clic4-/- embryos were growth restricted (23 somite; 23S) with cardiac edema and 
pooling of blood around the developing heart as compared to Clic1-/- littermates (27S). Scale 
bars; 400µm 
 














Figure 3.3 Clic1-/-;Clic4-/- embryos are embryonic lethal and display growth restriction with 
vascular defects  
A) Whole mount endomucin staining of E9.5 Clic1-/-;Clic4-/-  and Clic1-/- embryos. Reduced 
endomucin staining was observed in high magnification images of intersomitic vessels (middle) 
and brain capillary plexus (bottom). B) Quantification of intersometic vessel density by 
endomucin staining. C) Quantification of vessel density in the brain capillary plexus by 
endomucin staining intensity **p<0.001. Scale bars; 200µm (A upper panel), 50µm (A-middle 





















































Figure 3.4 E9.25 Clic1-/- ;Clic4-/- embryos exhibit reduced prior to growth restriction 
A) Whole mount endomucin staining of E9.25 Clic1-/-;Clic4-/-  and Clic1-/-embryos; both 
developed to the 23 somite stage (23S). scale bars; 200µm. Reduced endomucin staining 
observed in high magnification images of intersomitic vessels (middle), and brain capillary 
plexus (bottom), scale bars; 50µm. B) Quantitation of vascular density determined as 
endomucin intensity normalized to total area between the 1st and 5th somite. *p<0.05. C) 
Quantification of average number of branch points per brain capillary plexus. Branch points 










































































Figure 3.5 Generation of double knockdown of CLIC1 and CLIC4 in HUVECs  
A) Expression of CLIC1 and CLIC4 in control (scrambled), Clic1 (CLIC1-KD), Clic4 (CLIC4-KD) 
or double knockdown Clic1 and Clic4 (dKO) HUVEC determined by immunoblotting with 
antibodies against CLIC1 (αC1) or CLIC4 (αC4) 48 hours after infection. α-tubulin (αTub) 
immunoblotting performed as a loading control. B) Images of all cell lines 48 hours after 
lentivirus infection.  





































Figure 3.6 Combined loss of CLIC1 and CLIC4 induces apoptosis in HUVECs 
A) Quantification of number of trypan blue negative cells by cell counting 24, 36 and 48 hours 
post lentiviral infection represented as percent viable cells relative to scrambled control. 
*p<0.0005, **p<1X103 B). Quantification of apoptosis as percent annexin V-positive HUVEC 
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Endothelial Clic4 functions in retinal vessel development and lung 






The mouse retina is often used as a model system to study postnatal vessel 
development as it becomes vascularized through the process of angiogenesis. 
Immediately following birth, initiation of retinal angiogenesis is driven by hypoxia, which 
promotes VEGF-A secretion by astorcytes cells lining the inner surface of the retina[67]. 
Endothelial cells migrate and sprout out and away from the optic nerve towards VEGF-A 
gradient to build rudimentary capillary networks that form a primary vascular plexus 
reaching the periphery of the retina by postnatal day 8 (P8) (Figure 4.1). Endothelial 
cells then continue to proliferate, sprout and migrate deeper into the retinal tissue to 
form a secondary and intermediary vascular plexus[67]. Vascularization of the retina is 
completed by P21 in the mouse and follows tight temporal regulation. Thus, normal 
progression of retinal angiogenesis requires endothelial cell proliferation migration and 
ability to sprout and form rudimentary networks. Knockdown of CLIC1 or CLIC4 reduced 
endothelial cell proliferation, branching and network formation and knockdown of CLIC1 
impaired HUVEC migration[22, 32]. Clic4-/- mice exhibited reduced branching and 
immature vascular network in the deeper retinal plexus at P9[33]. In light of these 
findings, we hypothesized that CLICs regulate retinal angiogenesis progression.  
The vascular system in mammals has a critical role in supplying tissues with 
nutrients and clearing waste products. To accomplish this, the vasculature must be 
sufficiently permeable to allow the free passage of soluble small molecules and gases 
but to a much lesser extent, of plasma proteins. Vascular barrier breach is thought to 
occur either through induction of permeability through vascular endothelial growth factor 




chronic inflammation[68]. Vascular permeability is dramatically increased in acute 
inflammation and cancer and is strongly associated with tumor spread, metastasis and 
wound inflammation[68]. A central mechanism promoting vascular barrier formation 
involves the localization of junctional proteins such as VE-cadherin, ZO-1 and Occludin 
to endothelial cell junctions[69]. VEGF signaling induces phosphorylation of VE-
cadherin and ZO-1 proteins through Src-dependent mechanism resulting in their 
subsequent removal from endothelial junctions coinciding with a robust increase in 
vascular permeability[70]. Conversely, Rac1-GTP, activated through multiple endothelial 
signaling pathways overcomes the action of VEGF, promoting endothelial barrier 
reinforcement by localizing VE-cadherin and ZO-1 to endothelial cell junctions[71]. Our 
preliminary study with Clic4-/- mice implanted with Lewis Lungs Carcinoma (LLC) tumors 
showed that while tumor growth was indistinguishable in Clic4-/- and wild type 
littermates, tumor metastasis was increased in Clic4 null mice (Data not shown). Upon 
closer inspection, we found that vessels in tumors isolated from Clic4-/- mice exhibited 
atypical vessel architecture with intercalations of endothelial and basement membrane 
layers and aberrant localization of VE-cadherin in the luminal region of the vessels 
(Data not shown/Jennie Tung Thesis). We posited that VE-cadherin junctions are 
disrupted in tumor vessels of Clic4-/- mice causing increased vessel permeability that 
contributes to the observed increase in tumor metastasis.  
To elucidate the endothelial specific functions of Clic4 in murine retinal 
angiogenesis and vascular permeability regulation, we assessed neonatal primary 
plexus retinal development and lung vessel permeability in mice with specific loss of 




the retinal primary plexus with increased vessel branching and tip cells. We also 
determined that Clic1 cooperates with Clic4 during retinal angiogenesis as Clic1-/-
;Clic4ECKO pups showed an exacerbation of the vascular phenotype observed in retinas 
isolated from Clic4ECKO mice. Here we also demonstrated that Clic4 loss in endothelium 
leads to significant increase in vessel permeability in murine lungs implicating that Clic4 
functions to regulate vascular barrier integrity.  
  
RESULTS 
Endothelial Clic4 is required for postnatal murine retinal vascular development 
To elucidate endothelial Clic4 function in vascular development we assessed the 
effects of endothelial Clic4 loss on postnatal retinal angiogenesis. We crossed Clic4fl/fl 
mice with the tamoxifen-inducible Cdh5-CreERT2 transgenic driver line, which uses the 
VE-cadherin locus to drive expression. The resulting endothelial specific knockout of 
Clic4 will be referred to as Clic4ECKO. To validate that Cre recombination occurred 
efficiently in retinal vessels, we crossed Clic4ECKO mice with the mT/mG double 
fluorescent Cre recombinase reporter mouse line. The mT/mG mouse line expresses a 
membrane-targeted tdTomato (mT) prior to Cre excision and membrane-targeted EGFP 
(mG) following Cre excision (Fig 4.2A), thereby allowing distinction of recombined and 
non-recombined cells[72]. To evaluate Cre recombination, we isolated retinas at 
postnatal day 5 (P5) from Tamoxifen treated Clic4ECKO; mT/mG animals. We found that 
the majority of retinal vessels in Clic4ECKO; mT/mG mice were green after tamoxifen 
treatment indicating a high efficiency of Cre recombination in the retinal vasculature (Fig 




stained them with Isolectin-B4 to visualize the vasculature (Fig 4.3A-E). At P5, Clic4ECKO 
retinas exhibited reduced vessel outgrowth of the primary plexus compared to Clic4fl/fl 
littermates (Fig 4.3A,B). Clic4ECKO retinas also displayed increased vessel sprouting as 
seen by a significant increase in vessel density, number of branch points and 
endothelial tips cells (Fig. 4.3C-E).  
 
Clic1 cooperates with endothelial Clic4 during vessel development in the retinal 
primary plexus  
We previously demonstrated that CLIC1 and CLIC4 functionally overlap to 
promote endothelial cell viability and embryonic development. To determine if Clic1 
cooperates with endothelial Clic4 during retinal sprouting angiogenesis, we examined if 
the additional loss of Clic1 escalated the Clic4ECKO retinal vascular phenotype. We 
crossed Clic4ECKO with Clic1 null mice to generate Clic1-/-;Clic4ECKO mice and assessed 
vascular development of the retinal primary plexus at P5. Additional loss of Clic1 
resulted in a more severe vessel outgrowth defect (Fig 4.4A-C) compared to Clic1-/-
;Clic4fl/fl control retinas (Fig 4.4B,D-E). Clic1-/-;Clic4ECKO retinas exhibited a significant 
increase in vessel density (Fig 4.4B) with appearance of sheet-like structures and 
elevated number of branch points and tip cells at the leading front of the retina (Fig 
4.4D,E). We thus demonstrated that CLIC4 functions in endothelial cells during retinal 
vascular development and that CLIC1 cooperates with CLIC4 to regulate angiogenic 






Endothelial Clic4 functions to restrict vascular permeability in murine lungs  
To assess if endothelial Clic4 regulates vessel functionality in addition to 
postnatal vessel growth and sprouting, we examined whether lung vascular barrier is 
altered in animals with loss of endothelial Clic4. To assess vessel permeability we 
employed the Evan Blue Dye (EBD) lung extravasation assay[73]. EBD binds to 
albumin. Under physiologic conditions the endothelium is impermeable to EBD bound 
albumin, restricting it within the vessels. When vessel barrier is altered, the endothelium 
becomes permeable to albumin bound EBD allowing extravasation into lungs and other 
tissues[74]. The liver, which is permeable to albumin in physiological conditions, is used 
as a positive control for EBD extravasation[73].  
To evaluate lung vessel permeability we intercrossed Clic4ECKO/+ mice to 
generate Clic4ECKO and Clic4ECKO/+ animals for comparison with Clic4fl/fl littermates. At 4 
weeks of age, animals were injected with EBD intraperitoneally. After dye circulation for 
3 hours, lungs and livers were harvested for analysis. Clic4ECKO animals exhibited an 
increase in EBD lung extravasation, characterized by intensely blue colored lungs and 
uptake of up to 0.7 µg of EBD/g of tissue compared 0.1µg/g of tissue in lungs of Clic4fl/fl 
littermates (Fig 4.5). Clic4ECKO/+ lungs exhibited an intermediate permeability phenotype 
with 0.4µg/g of tissue of EBD accumulation compared to 0.7µg EBD/g of tissue in 
Clic4ECKO lungs (Fig 4.5B). Livers isolated from all three genotypes that were examined 
were comparable in color and had indistinguishable amount of EBD accumulation, 
indicating that dye injection and extravasation occurred similarly across all genotypes 
(Fig 4.4). Thus, loss of Clic4 in endothelium resulted in increased vessel permeability, 





Here we report that while viable Clic4 nulls displayed mild sprouting defects in 
the deep retinal plexus, postnatal endothelial loss of Clic4 resulted in hyper-sprouting 
and vascular outgrowth defects in the primary retinal plexus. The retinal defects 
observed in Clic4ECKO animals were exacerbated by the additional loss of Clic1. These 
results highlight CLIC4 function in retinal sprouting angiogenesis and imply that CLIC1 
cooperates with CLIC4 during retinal vessel growth. Additionally, we demonstrated that 
postnatal loss of endothelial CLIC4 caused increased lung vessel permeability 
suggesting a novel role for CLIC4 in maintenance of vascular barrier integrity.  
We found that CLIC4 functions in endothelial cells to promote vascular 
outgrowth of retinal vasculature. When retinal primary plexus was evaluated in mice 
with endothelial loss of Clic4, the extent of radial growth toward the periphery of the 
avascular retina was diminished. Retinal angiogenesis requires endothelial cell 
proliferation and migration, both processes that we have found to be regulated by 
CLIC1[22] and CLIC4[32]. As CLIC1 and CLIC4 function in promoting endothelial cell 
proliferation, the reduction in vascular outgrowth of the primary retinal plexus in 
Clic4ECKO retinas may occur due to reduced endothelial cell growth. This phenotype was 
exacerbated when CLIC1 was additionally lost in Clic1-/-;Clic4ECKO retinas, indicating 
functional redundancy of CLICs in endothelial cell growth and viability.  
The excess sprouting seen in retinal vasculature of mice lacking endothelial 
Clic4 is reminiscent of phenotypes seen in Notch mouse mutants, where Notch 
signaling prevents vessels from forming new sprouts[75]. Alternatively, vessel 




signaling restricts vascular sprouting in a flow dependent manner. The increase in 
vascular branching we observed in Clic4ECKO retinas appeared similar to the retinal 
phenotype in S1pr1 loss of function mice[52] suggesting that CLICs may function during 
the process of vessel maturation to restrict extraneous sprouting. Future studies are 
needed to determine whether CLIC4 functions in vessel maturation and what signaling 
events drive CLIC functions in this process.  
Viable Clic4-/- pups exhibited reduced branching in the deeper vascular plexus at 
P9 while the primary retinal plexus at P5 appeared to develop normally. This phenotype 
stands in contrast to the vascular hyper-sprouting phenotype we observed in Clic4ECKO 
retinas at P5. While global loss of Clic4 occurs during embryonic development in the 
entire body of the animal, endothelial loss of CLIC4 is induced temporally after birth, 
only in the vascular compartment of the animal. Thus it is possible that during 
embryonic development of Clic4-/- mutants, induction of Clic1 or another Clic gene 
occurred allowing functional compensation for Clic4 loss in postnatal retinal vessel 
development. In contrast, the temporal loss of Clic4 in endothelium occurs quickly, 
making induction of alternate Clic genes unlikely during this short time span.  
Furthermore, the vascular processes governing the development of the primary 
and deeper retinal plexuses could be different. Primary plexus growth focuses on the 
ability of endothelial sprouts to grow and migrate towards the vascular front. In contrast, 
deeper plexus development depends on sprouts ability to migrate and invade 
downwards[67]. While Clic4 may be required for both primary and deeper plexus 
growth, expression of different Clic members in different cell types of the developing 




and Clic4ECKO retinas. Future studies examining vessel development in the deeper 
plexus of Clic4ECKO retinas will elucidate in what capacity and stage of development 
endothelial Clic4 functions to regulate retinal sprouting angiogenesis.  
Vascular permeability is a highly regulated process and is often utilized as a 
read out for tissue-specific vessel functionality[69]. We found that haploid loss of 
endothelial Clic4 led to increased vessel permeability in murine lung, which was 
exacerbated upon loss of both copies of Clic4 in endothelium. VEGF signaling is 
considered to be a major pathway through which vascular permeability is induced, 
through two concerted mechanism.[69]. The first mechanism is the formation of 
transendothelial pores that are thought to occur from interconnected groups of vesicles 
and vacuoles that traverse the endothelium[78]. CLIC4 has been reported to localize to 
vesicles and vacuoles in endothelial cells[20] suggesting it could function in 
transendothelial pore formation. Alternatively, VEGF signaling induces phosphorylation 
and internalization of VE-cadherin from endothelial cell junctions causing vascular 
barrier breach and increased vessel permeability. S1P signaling through S1P1 overrides 
VEGF-mediated induction of vascular permeability by promoting assembly and 
maintenance of VE-cadherin adherence junctions and ZO-1 tight junctions in endothelial 
cells[48, 63]. Loss of Clic4 in endothelium caused an increase in lung vessel 
permeability and tumor vessels from Clic4 null mice showed disrupted VE-cadherin 
localization. We thus propose that Clic4 functions during development and pathology to 
promote vascular barrier integrity by regulating the localization or maintenance of VE-







































Figure 4.1 Angiogenesis in the developing mouse retina. Arrows depict sprouts with 
endothelial tip cells. Adapted from Gerhardt, H., et al. (2003). VEGF guides angiogenic 




Figure 1. Developmental retinal angiog nesis in the mouse. Arro  depi t end thelial tip 
cells. Adapted from Gerhardt, H., et al. (2003). VEGF guides angiogenic sprouting 































Figure 4.2 Cdh5-CreERT2 recombination efficiency in the mouse retina. A) Schematic 
diagram of the mT/mG construct before and after Cre-mediated recombination. mT/mG consists 
of a chicken β-actin core promoter (promoter) driving a loxP-flanked coding sequence of 
membrane-targeted tandem Tomato (mT) resulting in tdTomato expression and membrane 
localization in endothelial cells. After endothelial specific Cre recombination, the mT sequence is 
excised allowing the promoter to drive expression of membrane-targeted green fluorescent 
protein (mG). Arrows denote the direction of transcription. Triangles represent loxP sites for 
Cre-mediated recombination. PA denotes polyadenylation sequences. B) Retinas isolated from 
tamoxifen treated Clic4ECKO; mT/mG mice showing most retinal vessel in green indicating high 
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Figure 4.3 Endothelial Clic4 is required for murine retinal vascular development                                        
A) Whole mount staining with isolectin of P5 retinas from mice with endothelial deletion of Clic4 
(Clic4ECKO/) as compared to Clic4fl/fl littermates. Scale bars; 500µm(Top), 200µm (Middle) artery 
(A), vein (V). B) Quantification of vascular density determined as endomucin intensity 
normalized to total retinal area. C) Quantification of vessel outgrowth, represented as average 
vessel length from optic nerve to vascular front. D) Quantification of number of branch points 




























Figure 4.4 Clic1 cooperates with Clic4 in endothelium in retinal vascular development 
A) Whole mount isolectin staining of P5 retinas from Clic1-/-;Clic4ECKO and Clic1-/-;Clic4fl/fl (control) 
mice. Scale bars; 500µm(Top), 200µm (Middle) artery (A), vein (V). B) Quantification of vascular 
density determined as endomucin intensity normalized to total retinal area C) Quantification of 
vessel outgrowth, represented as average vessel length from optic nerve to vascular front. D) 
Quantification of number of branch points per field. E) Quantification of number of tip cells per 
























Figure 4.5 Endothelial Clic4 functions to restrict vascular permeability in murine lungs  
A) Clic4fl/fl(control) Clic4ECKO/+ and Clic4ECKO/ECKO mice were intrapertoneouly injected with 4µl/g 
of 1% EBD. 3 hours after dye injection lungs and livers were harvested and photographed. B) 
To quantify vascular leak, lungs were solubilized using formamaide, and EBD extravasation was 
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Clic1 and Clic4 function in the S1P pathway to regulate endothelial 







The S1P signaling pathway is a regulatory signaling cascade established to be 
critical for angiogenesis and vascular growth during development and in pathological 
situations[79]. S1P is a blood born, bioactive lysophospholipid which binds to three 
different G-protein coupled receptors in endothelium; S1P1, S1P2 and S1P3. S1P1 
receptor couples exclusively to the Gαi G-protein complex while S1P2 functions are 
known to be regulated primary through its coupling with Gα12/13 protein complex[46]. 
S1P3 receptor couples to three different G-protein subunits, Gαi, Gα12/13, Gαq. The 
functions of the S1P3 receptor in the Gαi and Gα12/13 signaling cascades are thought to 
be highly redundant to the those of S1P1 and S1P2[51]. Signaling through S1P3 and Gαq 
activates PLC leading to calcium signal transduction and endothelial cell contractility[80].  
The balance between signals propagated through Gαi and Gα12/13 are thought to 
tightly regulate endothelial cells functions and vascular development. In physiological 
concentrations, S1P preferentially binds to S1P1. Ligand binding leads to activation of 
the receptor associated heterotrimeric Gαi protein complex which transduces pro-
angiogenic signals through Ras and PI3K[47]. Activation of Ras induces ERK and 
promotes endothelial cell proliferation and survival. Induction of PI3K activates AKT and 
Rac1. AKT signals to maintain endothelial cell viability while Rac1 promotes endothelial 
cell migration and VE-cadherin junction formation[48]. Conversely, activation of Gα12/13 
G-protein complex by S1P2 leads to activation of RhoA and its effector ROCK resulting 
in inhibition of Rac1 mediated functions, such as migration and VE-cadherin junction 
assembly[50](Figure 1.1). RhoA signaling also stimulates cytoskeletal rearrangements 




Although CLIC proteins have been implicated in a variety of cellular functions in 
various cell types, the molecular mechanism through which CLICs mediate their 
functions is still poorly understood. In endothelium, CLIC1 and CLIC4 are essential for 
multiple pro-angiogenic functions such as proliferation, migration, tube formation, and 
vascular morphogenesis[22, 32]. Many of these functions are regulated by the S1P 
signaling pathway. A study by Ponsioen and colleagues demonstrated that CLIC4:GFP 
fusion protein transiently translocated to cell membrane in glioblastoma cells after S1P 
treatment, establishing the first substantial link between CLICs and S1P pathway[58]. 
As both CLICs and the S1P pathway regulate similar functions in endothelial cells and 
CLIC4 changes its cellular localization in response to S1P stimulation, we hypothesized 
that CLICs function as effectors in the S1P signaling cascade to promote angiogenesis.  
Here we establish that CLIC proteins function in distinct branches of the S1P 
pathway to regulate signal transduction and cellular functions in endothelial cells. We 
demonstrate that knockdown of CLIC4 in HUVECs reduced S1P-mediated activation of 
AKT and Rac1 and impaired their downstream functions, including endothelial cell 
migration, invasion, and VE-cadherin adherence junction formation. Conversely, CLIC4 
overexpression led to elevated basal levels of activated Rac1 and increased VE-
cadherin localization to adherence junctions in serum starved endothelial cells. 
Knockdown of CLIC1 reduced S1P-stimulated induction of AKT and Rac1. CLIC1 
knockdown effected AKT and Rac1 to lesser extent than CLIC4 knockdown and caused 
reduced HUVEC migration and VE-cadherin junction assembly. The effect of CLIC1 
knockdown was less severe compared to the observed defects in migration and VE-




inhibition of S1P-mediated induction of RhoA and formation of actin stress fibers. Thus 
we conclude that CLIC4 is an essential effector in the S1P1 signaling pathway. While 
CLIC1 shares functional redundancies with CLIC4 in the S1P1-Rac1 branch of the 
signaling pathway, CLIC1 is uniquely required in the S1P2 signaling to activate RhoA 
and mediate its downstream functions.   
 
RESULTS 
CLIC4 relocalizes to cell membrane upon S1P stimulation in endothelial cells 
The first link between S1P pathway and CLIC proteins emerged from a study 
demonstrating that treatment with S1P induced re-localization of CLIC4 from the cytosol 
to the membrane in a glioblastoma line, implying a relationship between CLICs and S1P 
signaling pathway[58]. To examine how S1P affects CLIC4 localization in endothelial 
cells we ectopically expressed CLIC4:GFP fusion protein in HUVECs and examined its 
cellular localization upon S1P treatment. We found that S1P stimulation caused 
relocalization of CLIC4-GFP to cell membrane in a transient manner, where the 
maximum translocation occurred at 1 min post S1P treatment and dissipated by 5 min 
of treatment (Fig 5.1), similar to what has been previously reported in tumor cells[58].  
 
CLIC1 or CLIC4 is essential for S1P-mediated endothelial cell migration, invasion 
and VE-cadherin junction formation  
To investigate whether CLIC1 or CLIC4 regulate S1P-dependent endothelial cell 
functions, we utilized lentiviral vectors with CLIC1 or CLIC4 targeting shRNA to 




KD). These CLIC-KD HUVEC lines were analyzed in multiple in vitro angiogenesis 
assays. To assess the role of CLICs in endothelial cell migration we utilized an S1P-
driven Boyden chamber chemotaxic assay, described previously[50]. We found that 
HUVECs with either CLIC1 or CLIC4 knockdown exhibited a defect in migration towards 
S1P (Fig 5.2A). CLIC4-KD cells migrated significantly less toward S1P compared to 
CLIC1-KD cells (Fig 5.2B). Migration towards FBS of CLIC4-KD or CLIC1-KD cells was 
comparable to control HUVECs, thus serum components, likely other than S1P, 
promote migration of CLIC4-KD or CLIC1-KD cells. We examined whether S1P driven 
invasion into a collagen matrix required CLIC1 or CLIC4. We found that invasion into 
S1P-containing collagen matrix required endothelial cell expression of CLIC1 or CLIC4 
(Fig 5.3A). CLIC4-KD cells formed less invading sprouts in response to S1P than 
control cells. Sprouts formed from CLIC1-KD cells were reduced compared to control, 
but to a lesser extent than those seen in CLIC4-KD cells (Fig 5.3B).  
S1P signaling promotes formation of endothelial VE-cadherin adherence 
junctions which are essential for vascular barrier integrity maintenance[81]. We 
previously established that loss of endothelial Clic4 caused an increase in vascular 
permeability in murine lungs (Fig 4.5). We thus hypothesized that CLICs function to 
promote vascular barrier integrity through S1P mediated assembly of VE-cadherin 
junctions. To test this hypothesis we examined VE-cadherin localization to determine if 
VE-cadherin formed endothelial cell junctions in S1P treated HUVECs with CLIC1 or 
CLIC4 knockdown. Both CLIC1-KD and CLIC4-KD cells showed impaired localization of 
VE-cadherin to endothelial cell junctions in response to S1P addition (Fig 5.4A). CLIC4-




formation compared to CLIC1-KD (Fig 5.4B). These experiments demonstrated that 
CLIC1 or CLIC4 is required for S1P driven endothelial cell migration, invasion and VE-
cadherin junctions formation when studied using in vitro assays.  
 
CLIC1 or CLIC4 functions in S1P-dependent activation of AKT and Rac1 
Induction of migration or assembly of VE-cadherin junctions in endothelial cells 
occurs via S1P1 receptor signaling that activates AKT and Rac1 downstream of PI3K[48, 
50] (Figure 1.1). We sought to investigate whether activation of AKT and Rac1 is altered 
upon loss of CLIC1 or CLIC4 in HUVECs. S1P treatment induced phosphorylation of 
AKT after 10 min of S1P stimulation (Figure 5.5A). CLIC1-KD or CLIC4-KD in HUVECs 
exhibited reduced levels of phosphorylated AKT following S1P addition compared to 
scramble control (Fig 5.5A). CLIC4-KD cells had significantly lower levels of 
phosphorylated AKT in response to S1P compared to CLIC1-KD cells (Fig 5.5A).  
To evaluate Rac1 activation downstream of S1P we employed a G-lisa Rac1 
activating assay and performed analysis over several time points. S1P induced Rac1 
activity was observed at 1 minute of S1P addition and activity increased at 5 and 10 
minutes of S1P treatment. S1P mediated Rac1 activation was reduced in CLIC1-KD or 
CLIC4-KD HUVECs relative to control cells (Fig 5.5B). CLIC1-KD cells showed a 
reduced response to S1P and failed to induce Rac1 at 5 and 10 min of S1P treatment. 
CLIC4-KD cells failed to induce Rac1-GTP activation at 1, 5 or 10 min post S1P 
stimulation (Fig 5.5B). We thus demonstrated that CLIC1 or CLIC4 functions in the S1P 
pathway to activate AKT and Rac1 and mediate downstream migration and VE-cadherin 




knockdown, implying that CLIC4 is more critical for S1P dependent activation of AKT 
and Rac1 and is necessary for their downstream functions in endothelial cells.  
 
CLIC1 is required for S1P mediated actin stress fibre formation and RhoA 
activation 
S1P regulates different endothelial cell behaviors through distinct branches of 
the S1P receptor signaling cascade[79] (Fig 1.1). Signaling through S1P1 leads to 
downstream activation of AKT and Rac1 whereas signaling through S1P2 results in 
induction of RhoA leading to actin stress fiber formation and cell contractility[82]. We 
sought to determine whether endothelial CLICs function to promote cellular functions 
mediated by S1P2 signaling. Using immunofluorescence analysis with phalloidin actin 
we assessed formation of S1P-induced actin stress fibers in HUVECs with CLIC1 or 
CLIC4 knockdown. S1P-induced actin stress fibers formed normally in control and 
CLIC4-KD cells, while CLIC1-KD cells exhibited a severe impairment in actin stress 
fiber formation (Fig 5.6A). To assess RhoA activation in HUVECs with CLIC knockdown, 
we performed a G-lisa assay to follow the time course of S1P-stimulated RhoA 
induction. In accordance with CLIC1-KD stress fiber phenotype, knockdown of CLIC1 
caused reduced induction of RhoA after S1P treatment compared to control. CLIC4 
knockdown did not alter S1P-mediated RhoA activation (Fig 5.6B). Thus, we 
established that CLIC1 is required for S1P2 dependent activation of RhoA and formation 
of actin stress fibers in endothelial cells.  
Ectopic expression of CLIC4 elevates basal Rac1 signaling while CLIC1 




The loss of function studies we conducted indicated that S1P induced activation 
of Rac1 or RhoA is mediated by CLIC4 or CLIC1 respectively. To further elucidate the 
roles of CLIC1 and CLIC4 in Rac1 and RhoA signaling, we generated HUVEC cell lines 
with stable overexpression of CLIC1 or CLIC4. HUVECs were infected with lentiviruses 
expressing CLIC1 or CLIC4 cDNA and ectopic protein levels were validated by 
immunoblotting analysis (Fig 5.7A). Cell morphology and behaviour of CLIC1-OE and 
CLIC4-OE HUVECs appeared unchanged compared to control HUVECs (Fig 5.7B). To 
examine the effects of CLIC1-OE or CLIC4-OE on cellular events downstream of Rac1 
we assessed VE-cadherin junctions and actin localization in serum starved CLIC 
overexpressing HUVECs. Ectopic expression of CLIC4 but not of CLIC1 led to an 
increase in VE-cadherin localization to junctions. Ectopic expression of CLIC4 led to 
formation of cortical actin (Fig 5.8A), a cytoskeleton rearrangement indicative of 
activated Rac1[83]. Conversely, CLIC1 overexpression resulted in higher basal levels of 
actin stress fibers compared to control and CLIC4-OE cells (Fig 5.8A). Using Rac1 or 
RhoA G-lisa activation assays in serum staved HUVEC lines with CLIC overexpression; 
we found CLIC4-OE induced higher basal levels of Rac1-GTP while CLIC1-OE caused 
S1P-independent induction of RhoA-GTP (Fig 5.8B, C). These results further indicated 
that CLIC1 functions in the S1P2 receptor pathway to activate RhoA while CLIC4 is the 
most important effector necessary to activate Rac1 downstream of S1P1.  
 
DISCUSSION 
The S1P signaling cascade is a well established angiogenic regulatory 




junction formation[48]. To elucidate the molecular mechanisms through which CLICs 
function in endothelial cells, we established that CLIC1 and CLIC4 act as effectors in 
S1P signaling. We found that CLIC1 and CLIC4 have both overlapping and distinct 
functions in the S1P pathway. We determined that CLIC4 translocated to the cell 
surface upon S1P stimulation. CLIC1 or CLIC4 were both necessary for S1P-driven 
migration, invasion and VE-cadherin junction formation (Fig 5.9). S1P mediated 
activation of AKT and Rac1 required expression of CLIC1 or CLIC4 (Fig 5.9). We found 
that CLIC1 is necessary for S1P2 mediated induction of RhoA activation and 
downstream formation of actin stress fibres, whereas CLIC4 deficiency had little affect 
on RhoA mediated functions (Fig 5.9).  
In our studies, we consistently observed that knockdown of CLIC4 had a more 
severe effect on S1P1 signaling compared to CLIC1 knockdown. We propose that while 
CLIC1 and CLIC4 have overlapping functions in S1P1 signaling, CLIC4 is the dominant 
player. We previously established that CLIC1 and CLIC4 function overlaps to promote 
endothelial cell viability and murine embryonic development (Chapter 3). Thus, the in 
vitro studies we conducted were consistent with in vivo analysis with regards to CLIC1 
and CLIC4 functional redundancies in the S1P signaling pathway. Nevertheless, there 
are some distinct functions regulated by CLIC1 versus CLIC4. In endothelial cells, 
CLIC4 knockdown impeded S1P-directed migration in Boyden chamber migration assay 
while it did not affect migration into an “open wound” of endothelial cell monolayers in a 
scratch migration assay[32]. In contrast, CLIC1-KD HUVECs had a defect in both S1P-
driven migration in a Boyden chamber assay and migration in full serum media 




broader effector of cell migration that regulates endothelial migration through multiple 
signaling mechanisms. Thus, we propose that CLIC4 is the primary effector mediating 
S1P directed migration, while CLIC1 may be regulating migration through numerous 
signaling pathways, S1P pathway being one of them.  
CLIC1 and CLIC4 share high level of sequence similarity, however, there are 
some defined structural differences between the two CLICs. Crystal structure and 
functional analyses indicate that both CLIC1 and CLIC4 posses a putative trans-
membrane domain (TMD) near the N-terminus[24, 85], CLIC4 has a nuclear localization 
signal (NLS) [86] and both CLICs contain glutathione-S-transferase (GST) region at the 
C-terminus[87] (Fig 5.10). A main distinction between CLIC1 and CLIC4 is found in their 
different predicted protein-protein interaction motifs. Based on amino acid sequence, 
CLIC4 is predicted to have both Src-homology 2 (SH2) and Src-homology 2 (SH3) 
protein binding motifs while CLIC1 is only projected to have the SH2 motif[88] (Fig 5.10). 
Numerous tyrosine kinases such as Src and FAK contain both SH2 and SH3 domains 
that bind to SH2 and SH3 peptide binding motifs[89, 90]. A key signaling mediator 
downstream of S1P1, PI3K contains both SH3 and SH2 domain in its regulatory 
subunit[91]. Since CLIC4 is predicted to have both SH2 and SH3 motifs, it may bind 
more strongly to PI3K compared to CLIC1, thus promoting endothelial functions 
downstream S1P1 more efficiently. Additionally, both SH2 and SH3 motifs may be 
important for S1P-dependent recruitment and activation of PI3K at the cell membrane. 
CLIC4, which translocates to the membrane upon S1P treatment, may facilitate PI3K 
membrane localization and activation through interaction with the SH2-SH3 binding 




membrane with the same efficiency as CLIC4. These are hypotheses that could be 
tested in future studies. 
We demonstrated that CLIC1 is required for RhoA activation downstream S1P2 
while CLIC4 is central for Rac1 activity downstream of S1P1. This observation suggests 
that CLIC1 and CLIC4 function as distinct regulators of RhoA or Rac1 respectively, with 
CLIC1 uniquely required for RhoA activation. It may be that CLIC1 and CLIC4 function 
in the S1P pathway by interaction with Guanine Exchange Factors (GEFs) adaptor 
proteins that facilitate interactions between small GTPases and their associated GEFs. 
GEFs are effectors that facilitate activation of small GTPases by promoting exchange of 
GDP to GTP. Multiple GEFs are known to contain SH2 and SH3 domains through which 
they bind to GEF-adaptor proteins[92]. The difference in adaptor protein binding 
capacity between the different GEFs dictates GEF target specificity. Thus, the 
differences in SH2 and SH3 binding motifs between CLIC1 and CLIC4 could 
differentiate between which GEFs a given CLIC can bind to. This property would be 
proposed to mediate specific binding of CLIC4 to Rac1-GEF while CLIC1 may bind to 
either Rac1 or RhoA GEFs. Future structure-function studies using site-directed 
mutagenesis will elucidate which structural domains allow for the distinction between 












































Figure 5.1 CLIC4-GFP relocalizes to cell surface upon S1P stimulation  
S1P re-localizes CLIC4 to the cell surface. HUVEC expressing nuclear GFP (nGFP) or a CLIC4 
GFP fusion protein (CLIC4:GFP) were treated with1 mM S1P for 1, 2 and 5 min. S1P treatment 
localized CLIC:GFP to the cell surface (arrows) as compared to control (-S1P). DAPI 











































Figure 5.2 S1P driven HUVEC migration requires CLIC1 or CLIC4  
Migration of CLIC1-KD, CLIC4-KD or Scramble control HUVEC to 10nm, 100nm and 1mM S1P 
or FBS was determined by Boyden chamber assay. A) Crystal Violet dye staining of membrane 
on top of which cells have migrated. B) Quantification of cell migration using crystal violet 
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Figure 5.3 S1P-mediated invasion into 3D-collagen gels depends on CLIC1 or CLIC4 
CLIC1-KD, CLIC4-KD or Scramble control HUVEC are overlaid in collagen matrices laced with 
1µm S1P and allowed to invade into the matrix. A) After 24 hours the collagen matrix is fixed 
and stained with toluidine blue to allow visual morphological analysis of sprouts. B) 
Quantification of number of branching sprouts invaded into collagen matrix from top to longest 
sprout. *p<0.05, **p<0.005. 
 
  









































Figure 5.4 CLIC1 or CLIC4 mediate S1P-driven VE-cadherin junction assembly 
A) VE-cadherin IHC (green) to visualize adherence junction formation. Knockdown of CLIC1 or 
CLIC4 in HUVECs impairs VE-cadherin junction stimulation upon 100nm S1P treatment. Scale 
bar 200µm. B) Quantitation of cell surface VE-cadherin signal. * p < 0.005.  
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Figure 5.5 CLIC4 or CLIC1 are required for S1P-mediated activation of AKT and Rac1  
A) Immunoblotting analysis for phosphorylated (pAKT) and total (tAKT) showing that CLIC1-KD 
or CLIC4-KD reduces phospho-AKT level after 10 min 100nm S1P stimulation. B) Time course 
with starved (no S1P) and 100nm S1P stimulated for 1,5 and 10 minute HUVECs assessed with 
G-lisa Rac1-GTP activation assay demonstrating that S1P-mediated induction of Rac1-GTP is 
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 Figure 5.6 Knockdown of CLIC1 but not CLIC4 in HUVECs disrupts S1P-driven actin 
stress fibers and RhoA activation 
A) Phalloidin Actin IHC (red), Dapi (blue) to visualize actin stress fibers formation. Knockdown 
of CLIC1 but not of CLIC4 in HUVECs disrupts formation of actin stress fibers after stimulation 
with 100nm S1P. Scale bar 200µm.  B) Time course analysis using G-lisa RhoA-GTP activation 
assay with HUVECs stimulated with no S1P or 1,5, or 10 min with 100 nm S1P, demonstrating 
that S1P-mediated induction of RhoA-GTP is inhibited in CLIC1-KD but not in CLIC4-KD 

































































Figure 5.7 Generation of CLIC1 or CLIC4 overexpression in HUVECs 
A) Expression of CLIC1 and CLIC4 in control (MCS), CLIC1 (CLIC1-OE), CLIC4 (CLIC4-OE) 
HUVEC determined by immunoblotting with antibodies against CLIC1 (αC1) or CLIC4 (αC4). α-
tubulin (αTub) immunoblotting performed as a loading control.  B) Images of all cell lines 72 


































Figure 5.8 CLIC4 overexpression elevates basal Rac1 signaling while CLIC1 
overexpression induces basal RhoA functions in a S1P independent manner 
A) VE-cadherin (green) ,Phalloidin actin(red) and DAPI (blue) IHC, to visualize VE-Cadherin 
and actin stress fibers formation in serum starved HUVECs. CLIC4-OE causes increased basal 
VE-cadherin localization to junctions and cortical actin formation while CLIC1-OE led to increase 
in actin stress fibers. Scale bar 200µm B) G-lisa Rac1-GTP activation analysis in serum starved 
HUVECs demonstrating that CLIC4-OE leads to increase basal levels of activated Rac1-GTP. C) 
G-Lisa RhoA-GTP activation analysis in serum starved HUVECs showing that CLIC1-OE but 
not CLIC4-OE causes elevated RhoA induction in absence of S1P. *p<0.05 **p<0.005. 
 






















































































Figure 5.9 CLIC1 and CLIC4 function in S1P signaling pathway in endothelium 
A) CLIC1 and CLIC4 function in distinct branches of S1P signaling to regulates different cellular 
responses via S1P1 and S1P2. B) Effect of CLIC1 or CLIC4 knockdowns in HUVECs on S1P-
















































Figure 5.10 Comparison between predicted protein structures for CLIC1 and CLIC4 
Alignment of CLIC1 and CLIC4 structures based on predicted amino acid sequence. 
TMD-Predicted trans membrane domain region, Ion Channel- Ion channel similarity region, 
NLS- nuclear localization signal, SH3-Src homology 3 predicted binding motif, SH2-Src 
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Clic4 is required for S1P1 dependent regulation of retinal angiogenesis 






S1P signaling affects various aspects of vascular function such as cell 
adhesion[48], survival[93] and migration[84]. As such, S1P and the receptors it binds to 
are essential regulators of vascular development in embryogenesis[51], postnatal retinal 
angiogenesis[52] and pathological vessel growth in tumors[94]. Out of the three 
endothelial S1P receptors, S1P1 is the most abundantly expressed in endothelium and 
is the major receptor through which S1P induces angiogenesis and vessel growth[95]. 
Global deletion of the S1pr1 in mice results in embryonic lethality between E12.5-E14.5 
with severe hemorrhage and cardiac edema[51]. Analysis of the vasculature revealed 
reduced vascular smooth muscle cell coverage around the aorta and other large 
vessels of S1pr1 knockout embryos suggesting that the apparent vascular dysfunction 
occurred due to defects in vessel maturation[51]. Endothelial specific loss of S1pr1 also 
leads to embryonic lethality with similar vascular defects observed in global S1pr1 
knockout embryos[96]. In contrast, S1pr2 or S1pr3 global knockout mice are viable, 
fertile and do not exhibit apparent vascular defects[51]. Nevertheless, S1pr2 function 
becomes important in embryonic vascular development when S1pr1 is deleted as 
embryos deficient in both S1pr1 and S1pr2 exhibit a more severe phenotype, with 
bleeding and lethality occurring 2 days prior than in the S1pr1 single null embryos[51].  
In addition to its role in vascular embryonic development, S1P1 functions in 
regulation of postnatal vascular growth and angiogenesis in the murine retina. Mice with 
postnatal endothelial loss of S1P1 exhibit destabilized vascular network with increase in 
retinal endothelial branch points and tip cells[52, 53]. Endothelial gain-of-function of 




at the retinal primary plexus[52]. Based on these results, Jung and colleagues proposed 
a model that posits that upon blood flow initiation, S1P in the blood binds to S1P1 on 
endothelial cells lining the vessels of the retina to stabilize nascent vessels. Activated 
S1P1 signals to promote vessel quiescence through the assembly VE-cadherin 
junctions leading to restriction of vessel sprouting in the retina[52, 53]. Thus during 
embryogenesis and in postnatal vessel development S1P1 functions to promote vessel 
maturation through mechanisms that are dependent on blood flow initiation.  
The S1P signaling pathway plays a critical role in the maintenance of vascular 
barrier integrity. Adherence and tight junctions in endothelial cells are essential 
components that form the vascular barrier[68]. S1P1 signaling promotes the assembly of 
VE-cadherin adherence and ZO-1 tight junctions in endothelial cells through Rac1 
activity[48, 68]. S1P2 antagonizes S1P1 driven function in endothelial junction assembly 
through RhoA induction, leading to VE-cadherin phosphorylation and removal from cell 
junctions[54]. Pharmacological blockade of S1P1 receptor causes disruption of VE-
cadherin junctions leading to stark increase in vessel permeability, while treatment with 
S1P1 agonist overcomes VEGF-induced vascular permeability through maintenance of 
VE-cadherin on endothelial cell junctions[97]. Inhibition of S1P2 with a receptor 
antagonist restores VE-cadherin junction assembly and protects endothelial cells from 
H2O2-induced permeability in a rat lung perfused model[98]. Thus, a balance between 
signals propagated by S1P1 and S1P2 allows for proper regulation of vascular barrier 
formation and maintenance. We previously established that CLIC1 or CLIC4 is required 
for S1P1 mediated migration and VE-cadherin junction formation in endothelial cells. We 




loss of Clic4 appeared similar to that of retinas of S1pr1ECKO mice[52]. We thus 
hypothesized that endothelial CLICs are essential for S1P1-dependnet functions during 
postanatal angiogenesis and vascular barrier formation.  
Here we demonstrate that Clic4 is essential for S1pr1-mediated regulation of 
retinal angiogenesis and vascular permeability. Mice, in which Clic4 is deleted, both 
globally and in the endothelium, failed to respond to an S1pr1 agonist and exhibited a 
rescue of the hypo-sprouted agonist-induced vascular phenotype in the retinal primary 
plexus. Retinas from Clic1 null mice exhibited a partial response to an S1pr1 agonist. 
There results indicated that Clic4 is essential for S1pr1 function in retinal vascular 
development, whereas Clic1 is necessary but not sufficient. Using EBD lung 
permeability assay in Clic loss of function mice, we established that endothelial Clic4 is 
required for S1P1-induced regulation of vascular permeability while Clic1 is not essential 




Clic4 is essential for S1pr1 function in postnatal retinal angiogenesis  
To assess if Clics are required for S1pr1 function in retinal vessel development, 
we treated Clic knockout mice with the S1P1 receptor specific agonist SEW2871. 
Treatment with SEW2871 leads to decreased vessel sprouting and reduced vascular 
density in the primary retinal plexus[53]. We injected Clic4-/- and wild type littermates 
(Clic4+/+), with SEW2871 and collected retinas at P5 for analysis. Wild-type pups treated 
with SEW2871 exhibited reduced vascular density and decreased number of branch 




littermates exhibited vessel density and branch point numbers that were comparable to 
those observed in wild type controls, indicating that SEW2871 effect was ameliorated in 
Clic4-/- mutant mice (Fig 6.1A-C). In fact, the Clic4-/- phenotype in response to SEW2871 
was comparable to vehicle treated controls (Fig 6.1A-C). SEW2871 treatment in 
Clic4ECKO animals revealed analogous results. Agonist treated Clic4fl/fl mice showed 
reduction in retinal vascular density and branch point numbers compared to vehicle 
treated Clic4fl/fl littermates (Fig 6.1D-F). In contrast, SEW2871 treated Clic4ECKO retinas 
exhibited vessel density and vascular branching indistinguishable from vehicle treated 
Clic4ECKO and Clic4fl/fl littermate controls (Fig 6.1D-F). These results indicated that S1pr1 
function in retinal angiogenesis requires endothelial Clic4.  
 
Clic1 is necessary but not sufficient for S1PR1 signaling in retinal vessel 
development 
In vitro studies of S1P-mediated cellular functions downstream of S1P1 receptor 
have established that CLIC4 is a major effector in S1P1 signaling whereas CLIC1 
functions in this pathway but to a lesser extent. We thus sought to investigate whether 
Clic1 functions in vivo to mediate S1pr1 functions during retinal vessel development. We 
treated Clic1-/- and wild type littermates with SEW2871, an S1pr1 receptor agonist, and 
isolated retinas at P5 for vascular analysis. Retinas from SEW2871 treated Clic1-/- mice 
exhibited reduced vascular density that was comparable to SEW2871 treated wild type 
littermates (Fig 6.2A-B). Agonist treated Clic1-/- retinas showed increased number of 
vascular branch points compared to SEW2871 treated wild type controls (Fig 6.2A,C) 




Clic1 was lost in addition to endothelial Clic4 in Clic1-/-;Clic4ECKO mice, SEW2871 
treatment resulted in amelioration of the hyper-sprouted phenotype observed in vehicle 
treated Clic1-/-;Clic4ECKO (Fig 6.2 D-F). Specifically, vascular density and number of 
branch points in agonist treated Clic1-/-;Clic4ECKO retinas was comparable to that 
observed in retinas of vehicle treated Clic1-/-;Clic4fl/fl mice (Fig 6.2 E,F) suggesting some 
response to the agonist. All together these results indicated that CLIC1 is necessary but 
not sufficient for S1pr1-mediated function in retinal sprouting angiogenesis. 
 
S1P1-mediated regulation of vascular permeability requires endothelial Clic4 
S1P1 receptor signaling promotes endothelial barrier integrity via S1P-induced 
VE-cadherin adherence junction formation. In murine lungs, treatment with FTY720, an 
S1P1 receptor antagonist, caused a dose-dependent increase in lung vessel 
permeability[59, 99]. The loss-of-function studies we conducted in HUVECs have 
established that S1P-mediated VE-cadherin junctions assembly required CLIC1 or 
CLIC4 expression (Fig 5.4). We demonstrated that loss of endothelial Clic4 caused 
increased vessel permeability in murine lungs (Fig 4.5). We thus posit that S1P1-driven 
regulation of vascular permeability requires endothelial Clic4. To test this hypothesis, 
we utilized an EBD lung permeability assay and assessed whether blockade of S1P1 
receptor exacerbated the intermediate leakiness phenotype already recorded in 
Clic4ECKO/+ lungs (Fig 4.5). We first defined a dose that would induce a modest level of 
vascular leakiness, which was deemed to be 0.5 mg/kg FTY720 (Fig 6.3). We treated 4 
weeks old Clic4ECKO/ECKO, Clic4ECKO/+ and Clic4fl/fl littermates with vehicle or 0.5 mg/kg 




and harvested lungs for analysis of EBD extravasation. FTY720 treatment in Clic4fl/fl 
control mice led to a mild increase in lung vessel permeability with an accumulation of 
0.14µg of EBD/gm of tissue compared to 0.065µg of EBD in vehicle treated controls 
(Fig 6.3B). Lungs isolated from FTY720 treated Clic4ECKO/+ mice exhibited an increase 
in EBD accumulation with 0.55µg of EBD/gm of tissue in the lungs compared to 0.34µg 
of EBD in vehicle treated controls (Fig 6.3B). We were unable to assess difference in 
EBD accumulation in Clic4ECKO/ECKO animals as both antagonist and vehicle treated 
groups exhibited high levels of EBD extravasation in the lungs of about 0.65µg EBD/gm 
of tissue. Results from these experiments demonstrated that endothelial Clic4 functions 
in S1P1-medited regulation of vascular permeability.   
 
Clic1 is not necessary for S1P1 mediated inhibition of vascular permeability 
We have previously shown that CLIC1 expression was required for VE-cadherin 
junction assembly meditated by S1P1 signaling. As VE-cadherin junctions formation is 
critical for vascular barrier integrity we sought to assess whether Clic1 functions in lung 
vessel permeability and whether this function is mediated by S1pr1 signaling. We 
treated Clic1+/+ and Clic1-/- 4 weeks old littermates with vehicle, 0.5 mg/kg or 2 mg/kg of 
FTY720 and assessed vessel permeability using EBD lung permeability assay. We 
found that vehicle treated Clic1-/- lungs accumulated comparable amounts of EBD to 
lungs isolated from vehicle treated wild type littermates (Fig 6.4). Lungs isolate from wild 
type and Clic1-/- littermate controls did not exhibit significant differences in EBD 
accumulation after 0.5mg/kg or 2mg/kg FTY720 treatment (Fig 6.4B) suggesting loss of 





After birth, S1pr1 signaling functions to regulate several key processes in 
endothelium. In the retina, plasma-derived S1P transduces signals through S1pr1 that 
promote stabilization of the primary vascular network thus promoting suppression of 
ectopic sprout formation[52, 53]. In murine lungs, signaling through S1pr1 is essential 
for maintenance of vascular barrier integrity through assembly and conservation of VE-
cadherin adherence junctions in endothelial cells lining the lumen of the vessels[81]. 
Using pharmacological agents that modify S1pr1 signaling we established that 
endothelial Clic4 is required for S1pr1 functions in both retinal vascular growth and 
vessel permeability regulation in the lungs.  
Clic4ECKO retinas exhibited reduced vascular outgrowth with hyper-sprouted 
vasculature at P5, phenotypically similar to retinal vessel growth observed in S1pr1 loss-
of-function mice. These results suggested that CLIC4 and S1P1 pathways share 
functional commonalities and that Clic4, an intracellular protein, may function in S1P1 
signaling. In support of this hypothesis, we found that loss of Clic4 rescued the 
reduction of vessel density induced by treatment with S1pr1 agonist SEW2871. Thus, 
we conclude that S1pr1 function during retinal vessel growth requires endothelial Clic4.  
S1P1 is thought to promote vessel quiescence and restrict vessel sprouting 
through blood flow induced formation of VE-cadherin junctions in endothelial cells lining 
the vessels of the retina[52, 53]. We demonstrated that CLIC4 is a key effector 
mediating S1P-induced VE-cadherin junctions downstream of S1P1. Thus, loss of Clic4 
in vessels of Clic4ECKO retinas may lead to defects in formation or maintenance of VE-




sprouting resulting in a hyper-sprouted, unstable vascular primary plexus. Future 
studies examining VE-cadherin localization in Clic4ECKO retinas, both in physiological 
conditions and after SEW2781 treatment will corroborate whether Clic4 functions in 
endothelium to promote S1P1 dependent restriction of vessel sprouting through 
formation of VE-cahderin junctions.  
The process of VE-cadherin junction assembly and preservation is essential for 
the maintenance of vascular barrier integrity and is tightly regulated in endothelial cells 
through S1P1 receptor signaling. In HUVECs CLIC4 was necessary and sufficient to 
promote S1P-mediated VE-cadherin junctions. Clic4ECKO/+ mice exhibited increased lung 
vessel permeability that was further aggravated by either additional loss of the other 
Clic4ECKO allele (Fig 4.4) or by treatment with S1pr1 antagonist FTY720 (Fig 6.3). We 
thus propose that endothelial Clic4 functions in the S1P1 receptor signaling pathway to 
inhibit induction of vascular permeability through S1P-dependent formation of VE-
cadherin junctions.  
The dramatic increase in vessel permeability observed in Clic4ECKO/+ animals 
after mild blockade of S1P1 receptor with FTY720 suggests that CLIC4 functions in 
more then one capacity to mediate S1P1 dependent functions in vascular barrier 
maintenance. Distortion of ZO-1 tight junctions, assembly of which is also regulated 
through S1P1, causes vessel leakiness in lungs[100]. Thus, in addition to promoting VE-
cadherin junctions formation, CLIC4 could potentially function in S1P-mediated 
formation ZO-1 tight junctions. In Clic4ECKO/+ animals where Clic4 is partially lost in 
endothelium, mild inhibition of S1P1 receptor would appear to now completely block the 




vessel leakiness. Notably, we observed increased vessel permeability in Clic4ECKO/+ 
lungs independent of S1P1 blockade. Thus, it is possible that in addition to its function in 
the S1P1 signaling cascade, CLIC4 functions through additional signaling pathway to 
regulate vessel permeability.  
While our evidence does not suggest CLIC1 is the primary effector of S1P1 
signaling, CLIC1 regulated endothelial functions downstream of S1P1 in HUVECs. In 
accordance, retinas from Clic1-/- animals treated with SEW2871 exhibited a partial 
response to the agonist, with intermediate reduction in vessel density. Thus, loss of 
Clic1 in vessels of Clic1-/- retinas appears to be insufficient to diminish the key S1P1 
functions. This is likely due to the fact that Clic4 expressed in retinal vessels of Clic1-/- 
mice functionally compensates for loss of Clic1. Thus we conclude that Clic1 is 
necessary but not sufficient to mediate all S1pr1 functions in vascular growth of the 
developing retina.  
S1P2 function is antagonistic to that of S1P1 in lung vessel permeability. 
Signaling through S1P2 induces activation of RhoA, which blocks Rac1-stimulated VE-
cadherin junctions and promotes vascular leakiness[100]. Global loss of S1P2 represses 
induction of vessel permeability resulting in protection against LPS or FTY720 mediated 
induction of lung vessel permeability[101]. Based on results from functional studies in 
HUVECs, we propose that while CLIC1 shares functional redundancies with CLIC4 in 
the S1P1 signaling pathway, CLIC1 is required for S1P2 dependent induction of RhoA 
signaling. As Clic4 loss resulted in severe increase in vessel permeability in both 
physiological and agonist treated conditions, we expected that FTY720 treatment in 




protection against FTY720-induced vascular leakiness. Clic1-/- mice did not show any 
apparent induction of vascular permeability in either physiological or FTY720 treated 
conditions. As CLIC1 and CLIC4 have many overlapping functions, it is conceivable that 
in physiological conditions, Clic1 function in barrier maintenance will become important 
only in the context of Clic4 loss. Thus, it is possible that additional loss of Clic1 in 
Clic4ECKO/+ mice will aggravate the observed moderate increase in vessel permeability. 
Clic1 loss did not result in protection against FTY720 induced permeability potentially as 
a result of induction of another Clic gene that overcompensated for the loss of Clic1 
downstream of S1P2. Finally, as Clic1 is a global knockout; we cannot conclude that 











































Figure 6.1 Clic4 is required for S1pr1 function in postnatal retinal angiogenesis 
A) Whole mount Isolectin staining of P5 retinas from Clic4-/- and Clic4+/+(wild type) mice treated 
with SEW2871 S1pr1 agonist showing Clic4-/- failed to respond to agonist treatment. Scale bars; 
200µm. B) Quantification of vascular density determined as endomucin intensity normalized to 
total retinal area. C) Quantification of number of branch points per field. D) Whole mount 
Isolectin analysis of P5 retinas from Clic4ECKO/ECKO and Clic4fl/fl(control) mice treated with 
SEW2871 S1pr1 agonist or vehicle showing Clic4ECKO/ECKO animals did not respond to SEW2871 
agonist treatment exhibiting normal vessel density. Scale bars; 200µm. E) Quantification of 
vascular density determined as endomucin intensity normalized to total retinal area. F) 
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Figure 6.2 Clic1 is necessary but not sufficient for S1pr1 signaling in retinal vessel 
development 
A) Whole mount isolectin staining of P5 retinas from Clic1-/- and Clic1+/+(wild type) mice treated 
with SEW2871 S1pr1 agonist or vehicle showing partial agonist response. Scale bars; 200µm. B) 
Quantification of vascular density determined as endomucin intensity normalized to total retinal 
area. C) Quantification of number of branch points per field. D) Whole mount isolectin analysis 
of P5 retinas from Clic1-/-;Clic4ECKO/ECKO and Clic1-/-;Clic4fl/fl(control) mice. Scale bars; 200µm. E) 
Quantification of vascular density determined as endomucin intensity normalized to total retinal 
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Figure 6.3 Endothelial Clic4 promotes S1pr1-mediated regulation of vascular barrier 
integrity  
A) Clic4fl/fl(control) Clic4ECKO/+ and Clic4ECKO/ECKO mice were intraperitoneally injected with 
0.5mg/kg of FTY720. 24 hours after injection, mice were injected with 4µl/g of 1% EBD. After 3 
hours of dye circulation lungs were harvested and photographed. Lungs from Clic4ECKO/+ mice 
treated with FTY720 exhibited increased leakiness of EBD into the lungs compared to vehicle 
treated littermates of the same genotype. B) To quantify vascular leak, lungs were solubilized 































































Figure 6.4 Clic1 is not necessary for S1pr1 mediated inhibition of vascular permeability 
A) Clic1+/+(wild type) and Clic1-/- mice were intraperitoneally injected with vehicle, 0.5mg/kg or 2 
mg/kg of FTY720. 24 hours after injection, mice were injected with 4µl/g of 1% EBD. After 3 
hours of dye circulation lungs were harvested and photographed. Lungs from Clic1-/- vehicle 
treated mice did not exhibit any EBD accumulation and FTY720 treatment did not lead to 
increase in EBD accumulation that was higher then in wild type mice. B) To quantify vascular 
leak, lungs were solubilized using formamaide, and EBD extravasation was determined (see 
Methods) *p<0.005 **p<0.0005. 
 
  




















































































CLIC1 and CLIC4 function in distinct branches of the S1P pathway 





S1P binding to S1P1 receptor activates its associated Gαi G-protein complex 
that transduces pro-angiogenic signals. Ligand binding to S1P1 induces receptor 
conformational change that acts to catalyze exchange of GDP to GTP on Gαi leading to 
its activation and dissociation from the Gβγ dimer[102]. GTP-bound Gαi functions to 
inhibit adenelyl cyclase causing a reduction in intracellular levels of cyclic adenosine 
monophosphate (cAMP)[103]. Activated Gβγ binds the Ras protein in a complex with its 
associated GEF, recruits the complex to the membrane causing Ras induction and 
downstream ERK activation[104]. In addition, Gβγ subunit recruits PI3K to the 
membrane and promotes its autophosphorylation and subsequent activation[105]. In 
endothelial cells, activated PI3K localizes Rac1-GEF Tiam1 to cell membrane where it 
functions to activate Rac1[106]. Activated PI3K also recruits AKT to the cell surface 
leading to AKT phosphorylation and propagation of AKT-dependent signaling[107]. 
Pertussis toxin, a Gαi inhibitor functions to block exchange of GDP to GTP on Gαi 
subunit thus preventing its release from Gβγ and hindering subsequent signal 
transduction[103]. Respectively, pertussis toxin treatment is shown to efficiently block 
GPCR mediated activation of PI3K[108], Ras[109], and AKT[107] in endothelial cells.  
While S1P2 receptor couples weakly with Gαi, it functions primarily through its 
interaction with Gα12/13 heterotimeric G-protein complex. Ligand induced S1P2 
conformational changes cause Gα12/13 dissociation to release the associated Gβγ 
heterodimer. In endothelial cell, activated Gα13 binds to p115 RhoGEF and promotes 
RhoGEF-dependent recruitment and activation of RhoA on the cell surface[110, 111]. 




fully understood. Hence, there are no pharmacological agents directly targeting the 
signaling function of the Gα13 subunit. Nevertheless, global knockout of Gα13 in mice 
caused in utero lethality at E10.5 with severe defects in vessel organization and 
reduced vascular content[112], highlighting the critical functions of the Gα12/13 family of 
G proteins during vascular development.  
To maintain signaling, S1P receptors are reactivated through a tightly regulated 
process involving endosome dependent internalization and recycling back to the 
membrane[113]. One of the first steps in this process is receptor C-terminal 
phosphorylation by specific GPCR kinases (GRKs), which occurs shortly after receptor 
activation[114]. GRK receptor phosphorylation promotes β-arrestins binding to 
phosphorylated sites on receptor C-terminal tail resulting in receptor uncoupling from its 
associated G-protein and internalization into to the cell[115]. Internalized receptors are 
recycled back to the membrane through the endosomal pathway leading to receptor 
resensitization and sustained signaling. Perturbation of receptor recycling targets 
internalized receptors to the proteosome for degradation, resulting in down regulation of 
signal transduction[49]. Treatment with the S1P analogue, FTY720 leads to S1P1 
receptor irreversible internalization and consequent proteosomal degradation both in 
vitro[116] and in vivo[74, 117]. Recent evidence indicates that receptor internalization is 
an early step in an alternative, β-arrestin-dependent signaling mechanism that functions 
to activate intracellular signaling pathways such as PI3K and ERK[49, 118].  
We have established that CLIC1 and CLIC4 have overlapping functions in the 
S1P1 pathway and are both required for induction or Rac1 and AKT downstream of 




signaling cascade. We demonstrated that CLIC4 translocated to the membrane upon 
S1P addition. We thus propose that CLICs function on the cell surface to mediate 
signaling in distinct branches of S1P signaling. Here we show that CLIC1 and CLIC4 
are not essential for activation of Ras and ERK downstream of S1P1 receptor 
suggesting CLICs functions specifically in the S1P1-PI3K signaling cascade. Using 
pharmacological inhibition of different S1P receptors pathway components in HUVECs 
with CLIC overexpression, we delineated that CLIC4 functions downstream of the S1P1 
receptor between the Gβγ subunit and PI3K. We determined that CLIC1 functions 
downstream of the S1P2 receptor to mediate RhoA signaling. Additionally, we propose 
that CLIC4 could function in S1P1 receptor trafficking as we demonstrated that 
knockdown of CLIC4 but not of CLIC1 reduced S1P1 intracellular internalization. 
 
RESULTS 
CLIC1 or CLIC4 are not essential for S1P-driven activation of Ras and ERK 
We previously demonstrated that CLIC1 and CLIC4 function in the S1P1-PI3K 
pathway to activate AKT and Rac1. We showed that knockdown of CLIC1 or CLIC4 
reduced HUVEC proliferation[22, 32]. As activation of Ras and ERK promotes 
endothelial cell growth, we sought to evaluate whether CLIC1 or CLIC4 are required for 
S1P-mediated induction of Ras signaling. Using a time course analysis of S1P signaling 
with a G-lisa Ras activation assay, we found that knockdown of CLIC1 did not affect 
S1P-mediated induction of Ras-GTP in all measured time points (Fig 7.1A). CLIC4-KD 
HUVECs exhibited a small but significant reduction in Ras induction at 5 min of S1P 




all other measured time points were indistinguishable between CLIC4-KD, CLIC1-KD or 
Scramble control cells (Fig 7.1A).  
Activation of Ras induces phosphorylation of ERK and promotes endothelial 
proliferation and survival[84]. We thus examined the effect of CLIC knockdown on S1P-
mediated ERK phosphorylation. Using a Ras G-lisa assay, we found that CLIC4-KD 
HUVECs exhibited a mild reduction in phospho-ERK levels at 5 minutes after S1P 
stimulation (Fig 7.1B), compared to control cells. No effects on S1P mediated Ras 
activation were seen in CLIC1-KD cells (Fig 7.1A). CLIC1-KD did not appear to have an 
effect on S1P-mediated phospho-ERK induction at this time point of analysis, as levels 
of ERK phosphorylation in CLIC1-KD HUVECs appeared comparable to control (Fig 
7.1B). These results indicate that CLIC1 or CLIC4 are not essential effectors in the S1P 
mediated activation of Ras and ERK signaling. 
 
CLIC4 functions downstream of S1P1 receptor to promote endothelial migration 
and VE-cadherin junctions 
We established that CLIC4 is a key effector in the S1P1-PI3K branch and 
required to promote S1P-mediated endothelial cell migration and VE-cadherin junction 
formation, and that S1P relocalized CLIC4 to cell membrane in endothelial cells (Fig 
5.1). Overexpression of CLIC4 resulted in S1P-independent formation of VE-cadherin 
junction and Rac1 activity, demonstrating that CLIC4 activates S1P1 signaling in the 
absence of the S1P ligand (Fig 5.8). We thus hypothesized that CLIC4 functions at the 
level or downstream of the S1P1 receptor. To address this hypothesis we treated control 




S1P-directed migration and VE-cadherin junction formation assays as functional 
readouts to assess the ability of CLIC4 overexpression to overcomes S1P1 blockade. 
VPC44116 treatment reduced endothelial migration in control HUVECs, reverting 
migration to basal levels seen without S1P addition. At 10nm and 100nm S1P, 
VPC44116 treated CLIC4-OE HUVECs migrated comparably to untreated control or 
untreated CLIC4-OE HUVECs suggesting complete rescue of S1P1 blockade (Fig 7.2A). 
At 1mM S1P, VPC44116 treated CLIC4-OE cells migrated more efficiently compared to 
VPC44116 treated control cells but exhibited reduced migration compared to untreated 
control or CLIC4-OE cells (Fig 7.2A) indicating that at highest S1P concentration 
analyzed, ectopic expression of CLIC4 partially rescued endothelial migration when 
S1P1 receptor was inhibited.  
S1P treatment induced VE-cadherin localization to cell junctions in control 
HUVECs and this was blocked by VPC44116 treatment (Fig 7.2B). VPC44116 treated 
CLIC4-OE HUVECs exhibited VE-cadherin junctional localization that was 
indistinguishable from S1P stimulated control or CLIC4-OE HUVECs suggesting that 
CLIC4 overexpression overcame S1P1 specific inhibition in VE-cadherin junction 
formation assay. Taken together these findings indicate that CLIC4 functions at the level 
or downstream of the S1P1 receptor. 
 
CLIC4 functions downstream of the S1P1-coupled G-protein complex to promote 
AKT and Rac1 activation 
To elucidate the signaling mechanisms promoted by CLICs in S1P1 signaling, 




complex immediately downstream of S1P1. Upon S1P addition, Gαi bound to GTP 
releases from Gβγ. In its free form, Gβγ recruits PI3K to the membrane leading to 
activation of AKT and Rac1 signaling[120]. To test where in relation to the G-protein 
mediated pathway CLICs are functioning, we examined whether CLIC1 or CLIC4 
overexpression allowed for AKT and Rac1 activation under conditions of  
pharmacological inhibition of Gαi or Gβγ. Treatment with Gαi inhibitor Pertussis toxin 
(PTX) blocked S1P induced phosphorylation of AKT in control cells (Fig 7.3A). After 
PTX addition, S1P treated CLIC4 overexpressing HUVECs exhibited similar levels of 
phospho-AKT as control cells and CLIC4-OE cells treated with S1P (Fig 7.3A). Thus, 
ectopically expressed CLIC4 overcame PTX mediated inhibition of Gαi and promoted 
activation of AKT. PTX treatment in CLIC1-OE and control HUVECs reduced S1P 
mediated activation of Rac1 in Rac1 G-lisa activity assay (Fig 7.3B). S1P/PTX treated 
CLIC4-OE cells showed S1P-depdnent Rac1 activity levels that were comparable to 
S1P treated control or S1P treated CLIC1-OE HUVECs indicating that ectopic CLIC4 
rescued PTX-induced inhibition of S1P-mediated Rac1 induction (Fig 7.3B).  
To test whether CLICs function downstream of Gβγ we utilized Gallein, a small 
molecule inhibitor that blocks Gβγ signaling in endothelial cells[121] and assessed S1P-
induced Rac1 activation. Gallein-treated HUVEC lines with CLIC1 or CLIC4 
overexpression were assessed for S1P-induced Rac1 activation. Gallein treatment 
blocked S1P-mediated induction of Rac1-GTP in control and CLIC1-OE HUVECs (Fig 
7.3C). S1P-mediated Rac1-GTP induction was comparable between S1P/Gallein 
treated CLIC4-OE cells and S1P stimulated CLIC4-OE and S1P treated CLIC1-OE cells 




and activated Rac1 downstream. Rescue of Gαi and Gβγ inhibition of S1P-mediated 
Rac1 activation by ectopically expressed CLIC4 indicates that CLIC4 functions 
downstream or at the level of the heterotimeric G-protein complex in S1P1 signaling 
pathway. 
 
CLIC4 functions upstream of PI3K in S1P-dependent AKT and Rac1 stimulation 
Gβγ mediated activation of PI3K induces activation of AKT and Rac1 
downstream of S1P1. We previously determined that CLIC4 overexpression overcame 
inhibition of either S1P1 receptor or its associated G-protein complex. To assess 
whether CLIC4 functions upstream of PI3K, we examined AKT phosphorylation and 
Rac1 activation in CLIC4-OE, CLIC1-OE and control HUVECs treated with both S1P 
and with wortmannin, a specific PI3K inhibitor[122]. CLIC4 overexpression in HUVEC 
did not overcome wortmannin-mediated inhibition of PI3K activation after S1P treatment. 
Wortmannin treated CLIC4-OE cells showed reduced levels of S1P-mediated phospho-
AKT that were comparable to Wortmannin/S1P treated control cells (Fig 7.4A). Similarly, 
S1P-mediated induction of Rac1 was reduced in wortmannin treated control and CLIC4-
OE HUVECs stimulated with S1P (Fig 7.4B) indicating that CLIC4 overexpression did 
not rescue PI3K blockade and therefore CLIC4 likely functions upstream of PI3K.  
 
CLIC1 functions downstream of S1P2 to promote RhoA mediated functions 
We demonstrated that CLIC1 was required for S1P2 mediated activation of 
RhoA and formation of actin stress fibers (Fig 5.6). We determined that CLIC4 functions 
downstream of the S1P1 receptor. We postulated that CLIC1 functions on the cell 




pathway. To examine whether CLIC1 functions downstream of S1P2, we treated 
HUVEC cell lines with JTE013, an S1P2 specific inhibitor[123]. We then assessed if 
CLIC1 or CLIC4 overexpression rescued JTE013 mediated inhibition of RhoA induction 
and actin stress fibres formation. JTE013/S1P treated CLIC4-OE cells exhibited 
reduced levels of activated RhoA comparable to JTE013/S1P treated control cells. 
CLIC1-OE HUVECs treated with both S1P and JTE013 induced S1P-mediated RhoA 
activation, indistinguishably from S1P treated control or CLIC4-OE HUVECs (Fig 7.5A) 
implying that ectopically expressed CLIC1 rescued S1P2 specific inhibition by JTE013.  
JTE013 treatment blocked S1P-induced actin stress fibre formation in control 
and CLIC4-OE HUVECs (Fig 7.5B). JTE013 treated CLIC1-OE cells exhibited normal 
S1P-induced stress fiber formation that was comparable to S1P treated control, CLIC4-
OE and CLIC-OE HUVECs (Fig 7.5B) demonstrating that CLIC1 overexpression 
overcame S1P2 receptor blockade. Taken together, these results indicate that CLIC1 
functions in S1P2 pathway downstream or at the level of the GPCR (S1P2).   
 
CLIC4 but not CLIC1 regulates S1P1 receptor internalization in endothelial cells  
S1P receptor resensitization and recycling back to the plasma membrane are 
required for maintenance of receptor steady-state surface levels and continuous 
signaling[113]. S1P1 internalization is an essential step in the process of receptor 
resensitization[63]. To investigate a potential mechanism through which CLICs function 
to promote S1P-dependent functions, we assessed whether CLIC1 or CLIC4 function in 
S1P1 internalization. To examine S1P1 localization in endothelial cells, we infected 
HUVECs with shRNA for CLIC1 or CLIC4 together with a lentiviral vector containing 




localization in the cell before and after S1P treatment. Knockdown of CLIC4 but not of 
CLIC1 inhibited S1P1 receptor internalization upon S1P treatment. While most 
S1P1:GFP localized to intracellular vesicles after S1P stimulation in CLIC1-KD and 
control cells, in CLIC4-KD HUVECs, S1P1:GFP localized primarily to cell membrane 
(Fig 7.6A), indicating that receptor internalization was impeded.  
As we observed a defect in receptor internalization in CLIC4-KD HUVECs, we 
sought to assess whether CLIC4-KD affected S1P1 receptor steady state protein levels. 
Using immunoblotting analysis for S1P1, we found that S1P1 receptor protein levels 
were unaltered between CLIC4-KD or CLIC1-KD HUVECs in both S1P treated and 
untreated conditions (Fig 7.6B). S1P1 protein appeared to be shifted upwards in S1P-
treated CLIC4-KD HUVECs compared to S1P-treated control and CLIC1-KD cells 
suggesting a potential alternate S1P1 protein modification (Fig 7.6B). 
 
DISCUSSION  
Ectopic expression of CLIC4 in endothelial cells overcomes pharmacological 
inhibition of S1P-mediated Gαi and Gβγ activity but not of PI3K activation. Additionally, 
knockdown of CLIC4 or CLIC1 did not significantly impair activation of Ras or ERK 
signaling. As S1P causes relocalization of CLIC4 to cell surface, we posit that S1P 
signaling promotes translocation of CLIC4 to the membrane where it functions in the 
S1P1-PI3K pathway downstream of S1P1 receptor, either at the level of the G protein 
complex or as an effector bridging Gβγ and PI3K.  
Upon receptor activation, release of Gαi from its associated Gβγ subunit is 




Treatment with pertussis toxin blocks Gαi exchange of GDP to GTP consequently 
inhibiting release of Gβγ from its associated Gαi subunit. Ectopic expression of CLIC4 
rescued pertussis toxin inhibition of S1P-mediated signaling suggesting that CLIC4 may 
facilitate release of Gβγ regardless of Gαi nucleotide bound state. This hypothesis is 
further supported by the fact that CLIC4 overexpression rescued S1P1 receptor 
inhibition and mediates migration and VE-cadherin junctions downstream. VPC44116 is 
a competitive inhibitor that binds to the active site of S1P1 receptor and outcompetes 
the S1P ligand[119]. VPC44116 treatment blocks receptor conformational change and 
thus inhibits Gαi dissociation from Gβγ. Ectopic expression of CLIC4 overcame 
VPC44116 inhibition indicating that CLIC4 either stimulates Gβγ release from the G-
protein complex or promotes Gβγ signaling irrespective of G-protein dissociation.  
CLIC4 rescue of Gβγ inhibition but not of PI3K indicates that CLIC4 could 
function as an effector bridging Gβγ and PI3K thus facilitating PI3K activation on the cell 
surface. CLIC4 levels at the cell surface were increased upon S1P addition, suggesting 
that CLIC4 localization to the cell surface membrane may be important for its function in 
S1P signaling. CLIC4 is predicted to contain SH2 and SH3 protein binding motifs[88] 
through which it can potentially bind to PI3K. We propose that CLIC4 interacts with 
cytosolic PI3K through SH2-SH3 binding motifs. We propose that upon S1P addition, 
CLIC4 relocalizes to the membrane in complex with PI3K and facilitates PI3K interaction 
with Gβγ leading to PI3K activation and downstream signal transduction.  
S1P-mediated activation of AKT through PI3K has a feed-forward regulatory 
loop in S1P1 signaling. At the cell surface, activated AKT phosphorylates the C-terminus 




required for Rac1 mediated migration but is indispensible for functions downstream of 
Gαi[124]. We established that CLIC4 is a key effector in S1P-mediated activation of both 
AKT and Rac1. Thus, it is possible that CLIC4 functions to specifically activate Rac1 
through an AKT-dependent transactivation of S1P1 receptor. In support of this 
hypothesis, we found that CLIC4 but not CLIC1 is required for S1P1 internalization after 
ligand binding, an event that is essential for AKT-mediate receptor transactivation[124, 
125]. Future studies in CLIC knockdown HUVECs examining S1P1 specific 
phosphorylation by AKT and consequent internalization will elucidate whether CLIC4 
functions in receptor transactivation to mediate specific Rac1 activity.   
Our finding that CLIC4 overexpression overcame pharmacological inhibition of 
activated components of the heterotrimeric G-protein complex suggests that CLIC4 may 
function to activate AKT and Rac1 through a mechanism that does not depend on 
receptor associated G-protein signaling. β-arrestins bind to GPCRs after GRK-mediated 
receptor phosphorylation and promote receptor association with clathrin, leading to its 
internalization into the cell[49]. β-arrestin signaling has been reported to promote GPCR 
signaling in endosomes after receptor internalization[118]. Specifically, β-arrestin 
dependent induction of GPCR signaling in endosomes reportedly activated AKT, ERK 
and PI3K independently of G-protein activation, making this process resistant to 
pertussis toxin inhibition[126]. We demonstrated that CLIC4 knockdown hampered S1P1 
receptor internalization and CLIC4 overexpression overcomes pertussis toxin and 
Gallein inhibition. Therefore, it is possible that CLIC4 functions in S1P1 signaling 
cascade through the β-arrestin pathway, which does not require G-protein activation but 




S1P1 internalization is an essential event in receptor recycling and this is 
required to maintain persistent signaling. Prolonged treatment with the S1P1 antagonist 
FTY720 in HUVECs increases receptor membrane localization, consequently leading to 
receptor polyubiquitination and proteosomal degradation[127]. As a result, FTY720 
treatment blocks AKT and Rac1 activation and their downstream respective signaling. 
CLIC4 has been reported to localize to endocytic vesicle suggesting a function in 
intracellular trafficking[17]. S1P1 internalization was impeded in cells with CLIC4-KD, 
suggesting that CLIC4 can regulate S1P1 signaling by promoting receptor internalization 
and recycling back to the membrane. Taken together, our findings suggest that CLIC4 
functions in S1P1 signaling through several mechanisms. One mechanism depends on 
G-protein mediated activation of PI3K and AKT, whereas another involves receptor 
internalization promoting β-arrestin dependent signaling or regulating S1P1 receptor 






































Figure 7.1 CLIC1 or CLIC4 are not essential for S1P-driven activation of Ras and ERK 
A) Time course with starved (no S1P) and stimulated with 100nm S1P HUVECs for 1, 5 and 10 
and 30 minute. Ras activation is assessed with G-lisa Ras activation assay demonstrating that 
S1P-mediated induction of Ras-GTP occurs normally in CLIC1-KD cells and is marginally 
reduced at 5 min of S1P treatment in CLIC4-KD HUVECs. *p<0.05. B) Immunoblotting analysis 
for phosphorylated (pERK) and total (tERK) from lysates of HUVECs stimulated with 100nM 
S1P for 5 min showing CLIC4-KD but not CLIC1-KD HUVECs have moderate reduction in 
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Figure 7.2 CLIC4 overexpression rescues S1P1 receptor inhibition to promote endothelial 
migration and VE-cadherin junctions assembly 
A) Quantification of crystal violet positive HUVEC cells migrated on top of membrane in Boydem 
chamber migration towards S1P. Assay demonstrated that addition of a S1P1 inhibitor 
(VPC44116) blocked S1P-driven migration of control HUVEC. CLIC4 overexpressing HUVEC 
overcame S1P1 inhibition, rescuing migration. *p < 0.05. B) VE-cadherin IHC (Red), Dapi (Blue) 
to visualize S1P (100nm)-mediated adherence junction formation in presence of S1P1 inhibitor 
(VPC) demonstrating ectopic expression of CLIC4 rescues VPC-mediated blockade of VE-
cadherin junction formation. Scale bars; 100µm. C) Quantitation of VE-cadherin signal on cell 
surface. *p<0.005 **p<0.0005     
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Figure 7.3 CLIC4 functions downstream of the S1P1-coupled G-protein complex to induce 
AKT and Rac1 activation 
A) Ectopic expression of CLIC4 rescues GαI inhibition (PTX). Immunoblotting analysis for 
phosphorylated (pAKT) and total (tAKT) showing that CLIC4-OE but not CLIC1-OE rescues  GαI 
(PTX)-mediated inhibition of phospho-AKT induction after 5 min of 100nm S1P stimulation. 
CLIC4-OE but not CLIC1-OE overcomes GαI (PTX) or Gβγ (Gallein) inhibition and activates 
Rac1 downstream. B) G-lisa for Rac1 activation in starved (no S1P) Inhibitor treated(PTX), 
100nm S1P stimulated (S1P) and S1P and inhibitor treated (PTX+S1P) HUVECs. C) G-lisa for 
Rac1 activation in starved (no S1P) Inhibitor treated (Gallein), 100nm S1P stimulated (S1P) and 
S1P and inhibitor treated (PTX+Gallein) HUVECs.*p<0.05 **p<0.005 
PTX - - + - + - 
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Figure 7.4 CLIC4 overexpression does not rescue PI3K inhibition and fails to activate 
AKT and Rac1  
A) Ectopic expression of CLIC4 does not rescue PI3K inhibition (WORT). Immunoblotting 
analysis for phosphorylated (pAKT) and total (tAKT) showing that AKT phosphorylation is 
blocked in CLIC4-OE HUVECs upon treatment with PI3K inhibitor wortmannin (WORT) after 
stimulation with 100nm S1P. B) G-lisa for Rac1 activation in starved (no S1P) inhibitor treated 
(WORT), 100nm S1P stimulated (S1P) and S1P and inhibitor treated (WORT+S1P) HUVECs 
showing CLIC4-OE HUVECs exhibit comparable inhibition of Rac1 induction as MCS (control) 
cells indication that CLIC4 overexpression does not rescue Wortmannin-mediated blockade of 
Rac1 induction.  
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Figure 7.5 Ectopic expression of CLIC1 but not CLIC4 rescues S1P2 blockade and 
promotes RhoA activation and actin stress fibres 
CLIC1-OE in HUVECs overcomes S1P2 receptor inhibitor (JTE013) to mediate RhoA induction 
and stress fiber formation A) Time course analysis using G-lisa RhoA activation assay with 
serum starved, inhibitor treated (JTE), 100nm S1P treated (S1P) and S1P and inhibitor treated 
(S1P+JTE) HUVECs demonstrating that S1P-mediated induction of RhoA-GTP is rescued in 
CLIC1-OE cells upon inhibition with S1P2 receptor inhibitor but not in CLIC4-KD HUVECs. 
*p<0.05 **p<0.005 B) Phalloidin Actin IHC (red), DAPI (blue) to visualize actin stress fiber 
formation. Treatment with S1P2 receptor inhibitor (JTE013) blocked 100 nm S1P-induced actin 
stress fibers. Ectopic expression of CLIC1 but not CLIC4 rescued S1P2 blockade and promoted 




















































































Figure 7.6 Knockdown of CLIC4, but not CLIC1 impairs S1P-driven S1P1 internalization in 
HUVECs 
A) CLIC4-KD or CLIC1-KD HUVEC expressing S1P1 fusion protein (S1P1:GFP) were treated 
with 1µM S1P for 30 min. S1P treatment localized S1P1:GFP to intracellular vesicles in 
Scramble(+S1P) and CLIC1-KD (+S1P) cells. S1P1:GFP localized primarily to cell surface in 
CLIC4-KD (+S1P). Scale bars 100µm. B) Immunoblotting analysis for steady state levels of 
S1P1 in absence and presence (1µM) S1P illustrating those overall protein levels of S1P1 are 
not altered in CLIC1-KD or CLIC4-KD HUVEC compared to scramble control. Arrow indicate 



































Here we demonstrate that Clic1 and Clic4 functionally overlap to promote 
endothelial cell viability and embryonic development. We show that endothelial Clic4 
functions in postnatal murine retinal angiogenesis and is essential for the maintenance 
of vascular barrier integrity in the lungs. We established that CLIC1 and CLIC4 function 
in distinct branches of the S1P pathway to regulate angiogenesis. CLIC4 functions in 
the S1P1 pathway to activate AKT and Rac1, and mediate S1P-induced endothelial cell 
migration and adherence junctions assembly. Murine Clic4 is necessary for S1P1-
mediated functions during retinal angiogenesis and in vascular permeability regulation. 
While CLIC1 shares functional redundancies with CLIC4 in the S1P1 signaling, CLIC1 is 
uniquely required for RhoA activation and actin stress fiber formation downstream of 
S1P2. These findings establish the role of CLICs in embryonic development, postnatal 
retinal angiogenesis, and define a molecular mechanism through which CLICs function 
to mediate their functions in endothelium.  
Double knockout Clic1;Clic4 mice died between E9.5 and E10 and displayed 
reduced vascular content and severe growth restriction just prior to death. Combined 
loss of CLIC1 and CLIC4 induced robust apoptotic cell death in HUVECs. We thus 
conclude that CLIC1 and CLIC4 functionally overlap to promote endothelial cell viability 
and embryonic development. We posit that vascular defects observed in Clic1;Clic4 
double mutant embryos occurred due to increased apoptosis in endothelial cells lining 
the developing vessels consequently leading to vessel retraction or occlusion. To 
explore this hypothesis one could investigate whether increased cell death occurs in 




Clic4ECKO retinas exhibited increased vessel sprouting and reduced vascular 
outgrowth. These retinal defects were exacerbated by the additional loss of Clic1 in 
Clic4ECKO mice. We thus conclude that CLIC4 expressed in endothelium functions in 
retinal sprouting angiogenesis and that CLIC1 cooperates with CLIC4 in this process. 
During retinal vessel development, endothelial cells lining new sprouts need to 
proliferate and migrate outward from the optic nerve to form the primary retinal plexus. 
We have established that CLIC4 is essential S1P1-driven endothelial cell migration. We 
thus postulate that the reduction in vascular outgrowth observed in Clic4ECKO retinas 
occurred either due to reduced endothelial cell viability, or impairment of migration in 
endothelial cells lining the vessels of retina. In vivo analysis demonstrated that CLIC4 is 
required for S1P1-mediated functions in retinal angiogenesis. We thus posit that loss of 
Clic4 in retinal endothelial cells impairs S1pr1-mediated induction of vessel maturation 
thus resulting in increased ectopic sprouting in Clic4ECKO and Clic1-/-;Clic4ECKO retinas.   
Loss of endothelial Clic4 induced vascular permeability in murine lungs 
indicating that Clic4 functions to promote vascular barrier integrity. Induction of Rac1, 
downstream of S1P1, leads to formation of endothelial cell junctions (both VE-cadherin 
and ZO-1) [48, 63] that strengthen the vascular barrier and prevent induction of vessel 
permeability. Our findings established that CLIC4 is essential for S1P-dependnent 
assembly of VE-cadherin junctions and activation of Rac1. We thus propose that loss of 
Clic4 impairs S1P1-mediated induction of VE-cadherin junctions in endothelial cells 
lining lung vessels of Clic4ECKO mice, causing disruption of junctional homeostasis that 
leads to vascular permeability. In addition to S1P signaling cascade, Rac1 also 




integrity in endothelium. Rac1 signaling promotes F-actin reorganization, leading to 
formation of focal adhesions that link intracellular junctional proteins with the 
extracellular matrix[128]. Focal adhesion formation, together with endothelial cell 
junctions reinforces the vascular barrier and prevents vessel leakiness. CLIC4 
reportedly binds F-actin suggesting a potential role in cytoskeletal reorganization[17] 
and overexpression of CLIC4 in HUVECs induced Rac1 activation in absence of S1P 
(Fig 5.8). Thus it is possible that CLIC4 mediates Rac1 dependent functions through 
multiple signaling mechanisms, all of which prevent induction of vascular permeability. 
We have established that CLIC4 functions in S1P1 signaling and is essential for 
activation of AKT and Rac1 and S1P-dependnet migration and VE-cadherin junctions 
formation in endothelial cells (Fig 5.9). We demonstrated that CLIC1 is needed for 
S1P1-mediated signaling, but is uniquely required for RhoA activation and actin stress 
fiber formation downstream of S1P2 (Fig 5.9). In vivo, we determined that Clic4 but not 
Clic1 is required for S1pr1-mediated regulation of vascular permeability. Clic4 was 
essential for S1P1-mediated functions in retinal vessel development while Clic1 was  
necessary but not sufficient for this S1pr1 action. These results corroborate our original 
hypothesis, driven by our in vitro studies, which highlight Clic4 as a key effector in the 
S1P1 signaling pathway. While Clic1 may be required for some functions downstream of 
S1P1, we posit that Clic1 has an essential role in mediating S1P2-dependent functions. 
To put this hypothesis to the test in vivo, we would examine whether loss of Clic1 in 
mice impairs specific S1P2-depentent functions.  
The dissociation of Gαi subunit from Gβγ facilitates Gβγ-dependent activation of 




AKT and Rac1 downstream of PI3K, loss of Clic4 did not greatly affect activation of Ras 
or ERK suggesting that CLIC4 functions specifically in Gβγ-PI3K signaling branch. 
Activated Gαi also functions to inhibit adenelyl cyclase causing reduction of cAMP 
levels. Analysis of cAMP levels in CLIC knockdown cells will ultimately determine 
whether CLIC4 functions specifically in the Gβγ-PI3K signaling branch.  
Our findings indicate that CLIC4 functions in the S1P1-PI3K pathway 
downstream of the GPCR, between the Gβγ heterodimer and PI3K. We propose that 
CLIC4 functions in this signaling branch through two potential mechanisms. Firstly, we 
posit that CLIC4 acts upstream of PI3K to facilitate its interaction with Gβγ consequently 
leading to PI3K activation. We propose that CLIC4 interacts with PI3K through its 
predicted SH2 and SH3 protein interaction motifs, binding sites of which are found on 
the catalytic subunit of PI3K[91]. We posit that upon S1P stimulation CLIC4 relocalizes 
PI3K to cell surface where it is activated by Gβγ causing subsequent induction of 
downstream signaling (Fig 8.1). Alternatively, we propose that CLIC4 functions on the 
levels of the heterotrimeric G-protein to facilitate dissociation of the G-protein complex. 
Pertussis toxin inhibits Gαi dissociation from Gβγ rending the G-protein complex 
inactive. CLIC4 overexpression overcame pertussis toxin inhibition and activated AKT 
and Rac1 downstream. We thus speculate whether CLIC4 is an effector that promotes 
release of Gαi from Gβγ leading to Gβγ-mediated activation of PI3K.  
Normally, ligand bound GPCRs act as classical GEFs of the heterotrimeric G-
protein, promoting exchange of GDP to GTP, G-protein dissociation and subsequent 
signaling[102]. However, some reports describe that GEF activity can be promoted by 




protein that recruits Rac1-GEF Tiam1 to cell surface and mediates GEF-dependent 
activation of Rac1[130]. CLIC4 interacts with 14-3-3ζ in fibroblasts[131] suggesting 
CLIC4 could regulate GEF-associated functions. We propose that S1P binding causes 
relocalization of CLIC4 to the plasma membrane where it facilitates release of Gβγ from 
its associated Gαi subunit, potentially through a GEF-dependent mechanism (Figure 
8.2). We posit that this specific mode of Gβγ activation will induce PI3K signaling but 
may not be essential for activation of Ras, thus providing a mechanism that would 
selectively promote specific functions downstream of S1P1 activation. 
Knockdown of CLIC4 impeded S1P1 receptor internalization implying that CLIC4 
may mediate S1P1 signaling through a G-protein independent mechanism that involves 
receptor intracellular trafficking. GPCR internalization is a key step in the process of 
receptor recycling which is necessary to maintain continuous signaling. S1P binding 
leads to GRK-mediated phosphorylation of S1P1 followed by β-arrestin binding[113] that 
promotes internalization of the receptor into endosomes[113]. Classically, β-arrestins 
binding is considered to facilitate receptor signal desensitization[113]. However, β-
arrestin dependent induction of GPCR signaling in endosomes has previously been 
reported and was shown to activate AKT, ERK and PI3K independently of G-protein 
activity[126]. CLIC4 reportedly localizes to the endoplasmic reticulum[17, 132] and is 
implicated in intracellular trafficking[17]. Thus it is possible that CLIC4 mediates β-
arrestin-dependent S1P1 internalization or promotes β-arrestin-mediated signaling of 
internalized S1P1 receptors that specifically activates the S1P1-PI3K signaling cascade 




mechanism of action, S1P1 receptor trafficking patterns and β-arrestin-mediated 
signaling should be assessed in endothelial cells with CLIC knockdown.  
Overexpression of CLIC1 rescued S1P2 specific blockade and mediated S1P-
induced RhoA activation and actin stress fibers, indicating CLIC1 functions downstream 
of S1P2 receptor. Ligand bound S1P2 receptor activates Gα12/13 subunit that recruits 
p115Rho-GEF causing subsequent RhoA activation[110]. We hypothesize that similarly 
to CLIC4, CLIC1 functions at the level of the heterotrimeric G-protein to facilitate 
dissociation of the G-protein complex rendering activity to the Gα12/13 subunit. If that 
were the case, it would suggest that CLICs have conserved GEF-like functions, where 
CLIC1 can bind multiple G-protein complexes, while CLIC4 exclusively binds to and 
mediates dissociation of the Gαi G-protein complex.  
Evidence from several studies suggests that CLICs function in multiple GPCR 
pathways in addition to the S1P signaling cascade. Lysophosphatidic acid (LPA) is a 
native ligand of LPA receptors, a family of GPCRs closely related to S1P 
receptors[133]. LPA treatment relocalizes CLIC4 to cell membrane in endothelial cells 
(data not shown) and tumor cells[58] suggesting CLIC involvement in the LPA pathway. 
CLIC4 reportedly interacts with histamine H3 GPCR and enhances receptor cell surface 
expression in neurons[134]. Further evidence for CLIC functions in GPCR signaling is 
provided by study that identified CLIC2 and CLIC4 as novel potential effectors in GPCR 
signaling based on cellular translocation behaviors[135]. Taken together, evidence from 
these studies suggests that CLICs may act as general effectors of GPCR signaling that 




this hypothesis, one would examine whether CLICs loss affects the function of multiple 














































Model 8.1 CLIC4 interacts with PI3K and induces signaling through S1P1-PI3K pathway 
S1P-induced activation of S1P1 leads to dissociation of receptor associated G-protein complex 
rendering Gβγ active. CLIC4 interacts with PI3K through predicted SH2-SH3 binding motifs and 
recruits it to the membrane in S1P-depdent fashion, facilitating PI3K interaction with activated 
Gβγ. Gβγ activates PI3K leading to activation of AKT and Rac1 and their subsequent 
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Model 8.2 CLIC4 mediates dissociation of S1P1 associated G-protein complex 
A) S1P stimulation promotes CLIC4 translocation to intracellular plasma membrane. B) At the 
membrane, CLIC4 promotes G-protein complex dissociation rendering Gβγ specific activity 
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Model 8.3 CLIC4 regulates S1P1 receptor internalization or signaling in endosomes 
A) CLIC4 promotes ligand induced S1P1 receptor internalization, potentially through the β-
arrestin (βarr) pathway. B) CLIC4 mediated β-arrestin (βarr)-dependenS1P1 signaling in 
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